<SEC-DOCUMENT>0001493152-24-044809.txt : 20241112
<SEC-HEADER>0001493152-24-044809.hdr.sgml : 20241112
<ACCEPTANCE-DATETIME>20241112164517
ACCESSION NUMBER:		0001493152-24-044809
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20241108
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241112
DATE AS OF CHANGE:		20241112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STRYVE FOODS, INC.
		CENTRAL INDEX KEY:			0001691936
		STANDARD INDUSTRIAL CLASSIFICATION:	FOOD & KINDRED PRODUCTS [2000]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				871760117
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38785
		FILM NUMBER:		241449255

	BUSINESS ADDRESS:	
		STREET 1:		5801 TENNYSON PARKWAY
		STREET 2:		SUITE 275
		CITY:			PLANO
		STATE:			TX
		ZIP:			75024
		BUSINESS PHONE:		646-565-3861

	MAIL ADDRESS:	
		STREET 1:		5801 TENNYSON PARKWAY
		STREET 2:		SUITE 275
		CITY:			PLANO
		STATE:			TX
		ZIP:			75024

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Andina Acquisition Corp. III
		DATE OF NAME CHANGE:	20161208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:SNAX="http://stryve.com/20241108">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_SNAX_stryve.com_20241108 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20241108_20241108 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0001691936 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000004" name="dei:EntityCentralIndexKey">0001691936</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="snax-20241108.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-11-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001691936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-08</xbrli:startDate>
        <xbrli:endDate>2024-11-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-082024-11-08_custom_ClassCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001691936</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SNAX:ClassCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-08</xbrli:startDate>
        <xbrli:endDate>2024-11-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-082024-11-08_custom_WarrantsEachExercisableForClassCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001691936</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SNAX:WarrantsEachExercisableForClassCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-08</xbrli:startDate>
        <xbrli:endDate>2024-11-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90A_edei--DocumentType_c20241108__20241108_z4i6qcpttP89"><ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current
Report</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_908_edei--DocumentPeriodEndDate_c20241108__20241108_zJxh3gdhrYg6"><ix:nonNumeric contextRef="AsOf2024-11-08" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">November 8, 2024</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20241108__20241108_zNjuQLJSzE3e"><ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000011" name="dei:EntityRegistrantName">STRYVE
FOODS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20241108__20241108_zhKBmH46m271"><ix:nonNumeric contextRef="AsOf2024-11-08" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityFileNumber_c20241108__20241108_z4vjjKMLfTTa"><ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000013" name="dei:EntityFileNumber">001-38785</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20241108__20241108_zCdmnkYjoaAh"><ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000014" name="dei:EntityTaxIdentificationNumber">87-1760117</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20241108__20241108_zM859LT5ByU5"><ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000015" name="dei:EntityAddressAddressLine1">Post
                                            Office Box 864</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressCityOrTown_c20241108__20241108_zLcavhQUqjq5"><ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000016" name="dei:EntityAddressCityOrTown">Frisco</ix:nonNumeric></span>,
    <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20241108__20241108_zuOswceCyII9"><ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000017" name="dei:EntityAddressStateOrProvince">TX</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressPostalZipCode_c20241108__20241108_zfsgaPV2OgC5"><ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000018" name="dei:EntityAddressPostalZipCode">75034</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_909_edei--CityAreaCode_c20241108__20241108_zlEhq94MpHY9"><ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000019" name="dei:CityAreaCode">(972)</ix:nonNumeric></span> <span id="xdx_90F_edei--LocalPhoneNumber_c20241108__20241108_zsFCF5dob7Qe"><ix:nonNumeric contextRef="AsOf2024-11-08" id="Fact000020" name="dei:LocalPhoneNumber">987-5130</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>Not
Applicable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report.)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--WrittenCommunications_c20241108__20241108_zWg5Vs2Q8qI1"><ix:nonNumeric contextRef="AsOf2024-11-08" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--SolicitingMaterial_c20241108__20241108_z0qpTcTrge5e"><ix:nonNumeric contextRef="AsOf2024-11-08" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20241108__20241108_zkY1Q1VRkMU8"><ix:nonNumeric contextRef="AsOf2024-11-08" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20241108__20241108_zpMVtYMGCxif"><ix:nonNumeric contextRef="AsOf2024-11-08" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--Security12bTitle_c20241108__20241108__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockMember_zdMeW7qTUNqb"><ix:nonNumeric contextRef="From2024-11-082024-11-08_custom_ClassCommonStockMember" id="Fact000025" name="dei:Security12bTitle">Class
    A Common Stock</ix:nonNumeric></span> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20241108__20241108__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockMember_zf8LvobMaeY9"><ix:nonNumeric contextRef="From2024-11-082024-11-08_custom_ClassCommonStockMember" id="Fact000026" name="dei:TradingSymbol">SNAX</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SecurityExchangeName_c20241108__20241108__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockMember_zuJ00zfAiE3k"><ix:nonNumeric contextRef="From2024-11-082024-11-08_custom_ClassCommonStockMember" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20241108__20241108__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForClassCommonStockMember_zFXEHvUd3xE3"><ix:nonNumeric contextRef="From2024-11-082024-11-08_custom_WarrantsEachExercisableForClassCommonStockMember" id="Fact000028" name="dei:Security12bTitle">Warrants,
    each exercisable for Class A Common Stock</ix:nonNumeric></span> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--TradingSymbol_c20241108__20241108__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForClassCommonStockMember_zyKp1KhIdGXh"><ix:nonNumeric contextRef="From2024-11-082024-11-08_custom_WarrantsEachExercisableForClassCommonStockMember" id="Fact000029" name="dei:TradingSymbol">SNAXW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SecurityExchangeName_c20241108__20241108__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForClassCommonStockMember_zQbvAVzfRae2"><ix:nonNumeric contextRef="From2024-11-082024-11-08_custom_WarrantsEachExercisableForClassCommonStockMember" format="ixt-sec:exchnameen" id="Fact000030" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20241108__20241108_zLFUNzDOZsAa"><ix:nonNumeric contextRef="AsOf2024-11-08" format="ixt:booleantrue" id="Fact000031" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_905_edei--EntityExTransitionPeriod_c20241108__20241108_zEpPwZgGSN4e"><ix:nonNumeric contextRef="AsOf2024-11-08" format="ixt:booleanfalse" id="Fact000032" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2024, Stryve Foods, Inc. (the &#8220;Company&#8221;) announced the pricing of a best efforts public offering of (i) 370,000
shares of its Class A common stock; (ii) prefunded warrants to purchase an aggregate of 3,300,886 shares of Class A common stock (the
&#8220;prefunded warrants); and (iii) 7,341,722 common warrants to purchase up to 7,341,722 shares of Class A common stock (the &#8220;Warrants&#8221;),
at a combined public offering price of $0.79 per share and Warrants. In connection with the offering, on November 8, 2024, the Company
entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with institutional investors. The Purchase Agreement
contains customary representations, warranties and agreements of the Company and the purchaser and customary indemnification rights and
obligations of the parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
prefunded warrants are immediately exercisable for an exercise price of $0.0001, and expire when exercised in full. The Warrants
have an exercise price of $0.79 per share, are exercisable following stockholder approval and have a term of exercise equal to five years
following date of the stockholder approval. The exercise price and number of shares of Class A common stock issuable upon exercise is
subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting the common
stock and the exercise price. The shares issuable upon exercise of the Warrants are subject to stockholder approval. The Company has
agreed to hold an annual or special meeting on or before January 11, 2025, to have stockholders approve the issuance of the shares of
Class A common stock underlying the Warrants pursuant to applicable Nasdaq rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the offering, on November 8, 2024, the Company entered into a Placement Agency Agreement (the &#8220;Placement Agency
Agreement&#8221;) with Roth Capital Partners, LLC (&#8220;Roth&#8221;) and Northland Capital Markets, as co-placement agents in connection
with the offering (the &#8220;Placement Agents&#8221;). The Company paid the Placement Agents a cash fee of 7.0% of the aggregate gross
proceeds raised in the offering and reimbursement of certain expenses. In addition, the Company issued to Roth warrants (the &#8220;Placement
Agent Warrants&#8221;) to purchase 367,088 shares of common stock (representing 10% of the number of shares of Class A common stock and
prefunded sold in the offering). The Placement Agent Warrants are immediately exercisable at an exercise price of $0.869 (or 110% of
the public offering price per share of common stock and common warrants offered in the offering) and will expire on the third
anniversary of the commencement of sales of the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s directors and executive officers, subject to certain exceptions, agreed</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not to offer, issue, sell, contract to sell, encumber, grant
any option for the sale of or otherwise dispose of any shares of common stock or other securities convertible into or exercisable or
exchangeable for common stock for a period of 90 days following the closing date of the offering without the prior written consent of
the Company and the Placement Agents, subject to certain exceptions. In addition, the Company has agreed to not issue any shares of common
stock or securities exercisable or convertible into shares of common stock for a period of 75</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">days following the closing date, subject to certain exceptions,
or enter into an agreement to issue securities at a future determined price, for a period of six months following the closing date,
which terms may be waived by the</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Agents
in their sole discretion and without notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Class A common stock, the prefunded warrants, the Warrants and the Placement Agent Warrants described above and the shares
of Class A common stock underlying the prefunded warrants, the Warrants and the Placement Agent Warrants were offered pursuant
to the Registration Statement on Form S-1 (File No. 333-282043), as amended, which was declared effective by the Securities and Exchange
Commission on November 8, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the offering occurred on November 12, 2024. The Company received net proceeds of approximately $2.6 million, after deducting
the estimated offering expenses payable by the Company, including the placement agent fees. The Company intends to use the net proceeds
from the offering for working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the offering, the Company also agreed to amend certain existing warrants originally issued on January 11, 2022,
to purchase up to 529,412 shares of its Class A common stock at an exercise price of $54.00 per share (the &#8220;Amended Warrants&#8221;)
to have a reduced exercise price equal to $0.79 per share, and the term extended to November 12, 2029, subject to stockholder approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summaries of the Purchase Agreement, the Placement Agency Agreement, the Warrants, the prefunded warrants, the Placement Agent
Warrant and the Amended Warrants do not purport to be complete and are subject to, and qualified in their entirety by, the forms of such
documents, which are filed as exhibits 1.1, 4.1, 4.2, 4.3, 4.4 and 10.1 to this Current Report on Form 8-K, which are incorporated by
reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01 Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued a press release announcing the pricing of the offering on November 8, 2024 and a press release announcing the closing
of the offering on November 12, 2024.&#160; A copy of the press release is furnished herewith as Exhibit 99.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits<i>.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0pt; text-indent: 0pt"><a href="ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Form of</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Agency Agreement,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dated November 8, 2024, between the Company, Roth Capital Partners, LLC, and Northland Securities, Inc..</span></a></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt">&#160;</td>
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1691936/000149315224043847/ex4-8.htm" style="-sec-extract: exhibit">Form of Common Warrant (incorporated by reference to Exhibit 4.8 included in the Company&#8217;s Form S-1/A filed on November 6, 2024.</a></span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1691936/000149315224043847/ex4-7.htm" style="-sec-extract: exhibit">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.7 included in the Company&#8217;s Form S-1/A filed on November 6, 2024.</a></span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1691936/000149315224043847/ex4-6.htm" style="-sec-extract: exhibit">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.6 included in the Company&#8217;s Form S-1/A filed on November 6, 2024.</a></span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-4.htm">Form of Amended Warrant.</a></span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt">&#160;</td>
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Securities Purchase Agreement dated November 8, 2024, between the Company and the purchaser party thereto.</a></span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release dated November 8, 2024.</a></span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt">&#160;</td>
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt">99.2</td>
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt"><a href="ex99-2.htm">Press Release dated November 12, 2024.</a></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt">&#160;</td>
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt">&#160;</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline
XBRL document)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
November 12, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STRYVE
    FOODS, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    R. Alex Hawkins</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R.
    Alex Hawkins</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJyNkMFOg0AQhp+Ad5hwJi2s7UFuSGhjpMZgo14XGHRT2CGz20ofybd0AZtejHGzyWYy///9M+v7gb+ljWqR4e2uyGGPXd9Ki1Bgg4y6QqdI7x9icG+B78pYltpO5cWYkvOg86wXYlW6xiQ9KYN1DFG0DG+XYgWhiG/WkOx8b+ynpBtVo7ZKtiB1DU9MPSu0ks8zYS8H0tSdp6gXZKNIO9winNtfIMJIwCOd5CfxwUCep74XTMfzt0zH3qmywaIenZC12Lk4M7uvd5qmOhpLXfwqeVzOZLL6yAbkShlZtrghTltpjNuzI/1sqTrssCuRnTMKhYjC5GeoCyAAdAjAKwMach81UiCBGQQT6Zcx/hn2F+0b62GOZw== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLACEMENT
AGENCY AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
8, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roth
Capital Partners, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">888
San Clemente Drive, Suite 400</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newport
Beach, CA 92660</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Northland
Securities, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150
S 5<SUP>th</SUP> Street, Suite 3300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minneapolis,
MN 55402</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Introduction</B>.
Subject to the terms and conditions herein (this &ldquo;<U>Agreement</U>&rdquo;), Stryve Foods, Inc., a company incorporated under the
laws of Delaware (the &ldquo;<U>Company</U>&rdquo;), hereby agrees to sell up to an aggregate of $2,900,000 of registered securities
(the &ldquo;<U>Securities</U>&rdquo;) of the Company, including, but not limited to, 370,000 shares (the &ldquo;<U>Shares</U>&rdquo;)
of the Company&rsquo;s Class A common stock, par value $0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), common stock purchase
warrants to purchase up to an aggregate of 7,341,772 shares of Common Stock (the &ldquo;<U>Common Warrants</U>&rdquo;), and pre-funded
common stock purchase warrants to purchase up to an aggregate of 3,300,886 shares of Common Stock (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo;
and, together with the Common Warrants, the &ldquo;<U>Warrants</U>&rdquo;; and the Shares and Warrants, the &ldquo;<U>Securities</U>&rdquo;)
directly to various investors (each, an &ldquo;<U>Investor</U>&rdquo; and, collectively, the &ldquo;<U>Investors</U>&rdquo;) through
Roth Capital Partners, LLC (&ldquo;<U>Roth</U>&rdquo;) and Northland Securities, Inc. (&ldquo;<U>Northland</U>&rdquo; and, together with
Roth, the &ldquo;<U>Placement Agents</U>&rdquo;) as co-placement agents. The documents executed and delivered by the Company and the
Investors in connection with the Offering (as defined below), including, without limitation, a securities purchase agreement (the &ldquo;<U>Purchase
Agreement</U>&rdquo;), shall be collectively referred to herein as the &ldquo;<U>Transaction Documents</U>.&rdquo; The purchase price
to the Investors for each Share and related Common Warrants is $0.79, and the purchase price to the Investors for each Pre-Funded Warrant
and related Common Warrants is $0.79, less the exercise price of the Pre-Funded Warrants of $0.0001. The Placement Agents may retain
other brokers or dealers to act as sub-agents or selected-dealers on their behalf in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby confirms its agreement with the Placement Agents as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1. Agreement to Act as Placement Agents</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On the basis of the representations, warranties and agreements of the Company herein contained, and subject to all the terms and conditions
of this Agreement, the Placement Agents shall be the exclusive placement agents in connection with the private offering and sale by the
Company of the Securities pursuant to the Company&rsquo;s registration statement on Form S-1 (File No. 333-282043) (the &ldquo;<U>Registration
Statement</U>&rdquo;), with the terms of such offering (the &ldquo;<U>Offering</U>&rdquo;) to be subject to market conditions and negotiations
between the Company, the Placement Agents and the prospective Investors. The Placement Agents will act on a reasonable best-efforts basis
and the Company agrees and acknowledges that there is no guarantee of the successful placement of the Securities, or any portion thereof,
in the prospective Offering. Under no circumstances will the Placement Agents or any of their &ldquo;Affiliates&rdquo; (as defined below)
be obligated to underwrite or purchase any of the Securities for its own account or otherwise provide any financing. The Placement Agents
shall act solely as the Company&rsquo;s agents and not as principals. The Placement Agents shall have no authority to bind the Company
with respect to any prospective offer to purchase Securities and the Company shall have the sole right to accept offers to purchase Securities
and may reject any such offer, in whole or in part. Subject to the terms and conditions hereof, payment of the purchase price for, and
delivery of, the Securities shall be made at one or more closings (each a &ldquo;<U>Closing</U>&rdquo; and the date on which each Closing
occurs, a &ldquo;<U>Closing Date</U>&rdquo;). As compensation for services rendered, on each Closing Date, the Company shall pay to the
Placement Agents the fees and expenses set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A cash fee equal to 7.0% of the gross proceeds received by the Company from the sale of the Securities at the closing of the Offering
(the &ldquo;<U>Closing</U>&rdquo;), excluding proceeds from officers and directors of the Company, existing noteholders and any individuals
or entities that the Company brings to the Offering (collectively, the &ldquo;<U>Company Investors</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Such number of Common Stock purchase warrants (the &ldquo;<U>Placement Agent Warrants</U>&rdquo;) to Roth or its designees at each Closing
to purchase shares of Common Stock equal to 10.0% of the aggregate number of Shares and Pre-Funded Warrants sold in the Offering, excluding
Securities sold to the Company Investors and proceeds from the cash exercise of the Warrants. The Placement Agent Warrants shall have
the same terms as the Common Warrants except that the Placement Agent Warrants shall have an expiration date of 3 years from the commencement
of sales in the Offering and an exercise price equal to $0.869. The Placement Agent Warrants shall not be transferable for six months
from the date of the Offering except as permitted by the Financial Industry Regulatory Authority (&ldquo;<U>FINRA</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Company also agrees to reimburse the Placement Agents&rsquo; expenses (with supporting invoices/receipts) of $50,000 payable immediately
upon the Closing of the Offering including amounts reimbursed or paid on behalf of the Placement Agents pursuant to Section 6(ix).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The term of the Placement Agents&rsquo; exclusive engagement will be until the completion of the Offering (the &ldquo;<U>Exclusive Term</U>&rdquo;);
<U>provided</U>, <U>however</U>, that a party hereto may terminate the engagement with respect to itself at any time upon 10 days written
notice to the other parties. Notwithstanding anything to the contrary contained herein, the provisions concerning confidentiality, indemnification
and contribution contained herein and the Company&rsquo;s obligations contained in the indemnification provisions will survive any expiration
or termination of this Agreement, and the Company&rsquo;s obligation to pay fees actually earned and payable and to reimburse expenses
actually incurred and reimbursable pursuant to Section 1 hereof and which are permitted to be reimbursed under FINRA Rule 5110(g), will
survive any expiration or termination of this Agreement. Nothing in this Agreement shall be construed to limit the ability of the Placement
Agents or their respective Affiliates to pursue, investigate, analyze, invest in, or engage in investment banking, financial advisory
or any other business relationship with Persons (as defined below) other than the Company. As used herein (i) &ldquo;Persons&rdquo; means
an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind and (ii) &ldquo;Affiliate&rdquo; means
any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with
a Person as such terms are used in and construed under Rule 405 under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2. Representations, Warranties and Covenants of the Company</B>. The Company hereby represents, warrants and covenants to the Placement
Agents as of the date hereof, and as of each Closing Date, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Securities Law Filings. The Company has filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) the Registration
Statement under the Securities Act, which was filed on September 11, 2024 and declared effective on November 8, 2024 for the registration
of the Securities under the Securities Act. Following the determination of pricing among the Company and the prospective Investors introduced
to the Company by Placement Agent, the Company will file with the Commission pursuant to Rules 430A and 424(b) under the Securities Act,
and the rules and regulations (the &ldquo;<U>Rules and Regulations</U>&rdquo;) of the Commission promulgated thereunder, a final prospectus
relating to the placement of the Securities, their respective pricings and the plan of distribution thereof and will advise the Placement
Agent of all further information (financial and other) with respect to the Company required to be set forth therein. Such registration
statement, at any given time, including the exhibits thereto filed at such time, as amended at such time, is hereinafter called the &ldquo;Registration
Statement&rdquo;; such prospectus in the form in which it appears in the Registration Statement at the time of effectiveness, together
with any preliminary prospectus supplement relating to the Offering, is hereinafter called the &ldquo;Base Prospectus&rdquo;; the preliminary
prospectus supplement in the form in which it was filed with the Commission pursuant to Rule 424(b) is hereinafter called the &ldquo;<U>Preliminary
Prospectus</U>&rdquo;; and the final prospectus, in the form in which it will be filed with the Commission pursuant to Rules 430A and/or
424(b) (including the Base Prospectus as it may be amended or supplemented) is hereinafter called the &ldquo;Final Prospectus.&rdquo;
The Registration Statement at the time it originally became effective is hereinafter called the &ldquo;Original Registration Statement.&rdquo;
Any reference in this Agreement to the Registration Statement, the Original Registration Statement, the Base Prospectus, the Preliminary
Prospectus or the Final Prospectus shall be deemed to refer to and include the documents incorporated by reference therein (the &ldquo;<U>Incorporated
Documents</U>&rdquo;), if any, which were or are filed under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
at any given time, as the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo;
or &ldquo;supplement&rdquo; with respect to the Registration Statement, the Original Registration Statement, the Base Prospectus, the
Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and include the filing of any document under the Exchange
Act after the date of this Agreement, or the issue date of the Base Prospectus, the Preliminary Prospectus or the Final Prospectus, as
the case may be, deemed to be incorporated therein by reference. All references in this Agreement to financial statements and schedules
and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set
forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the Base Prospectus, the Preliminary Prospectus Supplement or the
Final Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules
and other information which is or is deemed to be incorporated by reference in the Registration Statement, the Base Prospectus, the Preliminary
Prospectus or the Final Prospectus, as the case may be. As used in this paragraph and elsewhere in this Agreement, &ldquo;<U>Time of
Sale Disclosure Package</U>&rdquo; means the Base Prospectus, any preliminary prospectus, any subscription agreement between the Company
and the Investors, and any issuer free writing prospectus as defined in Rule 433 of the Act (each, an &ldquo;Issuer Free Writing Prospectus&rdquo;),
if any, that the parties hereto shall hereafter expressly agree in writing to treat as part of the Time of Sale Disclosure Package. The
term &ldquo;any Prospectus&rdquo; shall mean, as the context requires, the Base Prospectus, the Final Prospectus, and any supplement
to either thereof. The Company has not received any notice that the Commission has issued or intends to issue a stop order suspending
the effectiveness of the Registration Statement or the use of the Base Prospectus or the Prospectus or intends to commence a proceeding
for any such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Assurances</U>. The Original Registration Statement, as amended, (and any further documents to be filed with the Commission) contains
all exhibits and schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto,
at the time it became effective, complied in all material respects with the Securities Act and the applicable Rules and Regulations and
did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading. The Base Prospectus, and the Final Prospectus, each as of its respective date, comply or
will comply in all material respects with the Securities Act and the applicable Rules and Regulations. Each of the Base Prospectus and
the Final Prospectus, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. The Incorporated Documents, when they were filed with the Commission, conformed in all material respects to
the requirements of the Exchange Act and the applicable Rules and Regulations promulgated thereunder, and none of such documents, when
they were filed with the Commission, contained any untrue statement of a material fact or omitted to state a material fact necessary
to make the statements therein (with respect to Incorporated Documents incorporated by reference in the Base Prospectus or Final Prospectus),
in light of the circumstances under which they were made not misleading. No post-effective amendment to the Registration Statement reflecting
any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental change in the information
set forth therein is required to be filed with the Commission. Except for this Agreement, there are no documents required to be filed
with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities
Act or (y) will not be filed within the requisite time period. Except for this Agreement, there are no contracts or other documents required
to be described in the Base Prospectus or Final Prospectus, or to be filed as exhibits or schedules to the Registration Statement, which
have not been described or filed as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Offering Materials</U>. Neither the Company nor any of its directors and officers has distributed and none of them will distribute,
prior to each Closing Date, any offering material in connection with the offering and sale of the Securities other than the Time of Sale
Disclosure Package.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and the Time of Sale Disclosure Package and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of each of this Agreement by the Company and the consummation by it of the transactions contemplated hereby
and thereby and under the Base Prospectus have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Company&rsquo;s Board of Directors (the &ldquo;<U>Board of Directors</U>&rdquo;) or the Company&rsquo;s
stockholders in connection therewith other than in connection with the Required Approvals (as defined below). This Agreement has been
duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation
of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and
applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo;
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the transactions contemplated pursuant
to the Time of Sale Disclosure Package, the issuance and sale of the Securities and the consummation by it of the transactions contemplated
hereby and thereby to which it is a party do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any
Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with,
or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation
of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect (as defined in the Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Certificates</U>. Any certificate signed by an officer of the Company and delivered to the Placement Agents or to counsel for the
Placement Agents shall be deemed to be a representation and warranty by the Company to the Placement Agents as to the matters set forth
therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Reliance</U>. The Company acknowledges that the Placement Agents will rely upon the accuracy and truthfulness of the foregoing representations
and warranties and hereby consents to such reliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Forward-Looking Statements</U>. No forward-looking statements (within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act) contained in the Time of Sale Disclosure Package has been made or reaffirmed without a reasonable basis or has
been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>FINRA Affiliations</U>. There are no affiliations with any FINRA member firm that is participating in the Offering among the Company&rsquo;s
officers, directors or, to the knowledge of the Company, any five percent (5%) or greater stockholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Representations, Warranties and Covenants Incorporated by Reference</U>. Each of the representations, warranties and covenants (together
with any related disclosure schedules thereto) made to the Investors in the Purchase Agreement is hereby incorporated herein by reference
(as though fully restated herein) and is hereby made to, and in favor of, the Placement Agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3. Delivery and Payment</B>. Each Closing shall occur at the offices of Ellenoff Grossman &amp; Schole LLP, 1345 Avenue of the Americas,
New York, New York 10105 (&ldquo;<U>Placement Agent Counsel</U>&rdquo;) (or at such other place as shall be agreed upon by the Placement
Agents and the Company). Subject to the terms and conditions hereof, at each Closing payment of the purchase price for the Securities
sold on such Closing Date shall be made by Federal Funds wire transfer, against delivery of such Securities, and such Securities shall
be registered in such name or names and shall be in such denominations, as the Placement Agents may request at least one business day
before the time of purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deliveries
of the documents with respect to the purchase of the Securities, if any, shall be made at the offices of Placement Agent Counsel. All
actions taken at a Closing shall be deemed to have occurred simultaneously.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4. Covenants and Agreements of the Company</B>. The Company further covenants and agrees with the Placement Agents as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Registration Statement Matters</U>. The Company will advise the Placement Agent promptly after it receives notice thereof of the time
when any amendment to the Registration Statement has been filed or becomes effective or any supplement to the Base Prospectus or the
Final Prospectus has been filed and will furnish the Placement Agent with copies thereof. The Company will file promptly all reports
and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a),
14 or 15(d) of the Exchange Act subsequent to the date of any Prospectus and for so long as the delivery of a prospectus is required
in connection with the Offering. The Company will advise the Placement Agent, promptly after it receives notice thereof (i) of any request
by the Commission to amend the Registration Statement or to amend or supplement any Prospectus or for additional information, and (ii)
of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective
amendment thereto or any order directed at any Incorporated Document, if any, or any amendment or supplement thereto or any order preventing
or suspending the use of the Base Prospectus or the Final Prospectus or any prospectus supplement or any amendment or supplement thereto
or any post-effective amendment to the Registration Statement, of the suspension of the qualification of the Securities for offering
or sale in any jurisdiction, of the institution or threatened institution of any proceeding for any such purpose, or of any request by
the Commission for the amending or supplementing of the Registration Statement or a Prospectus or for additional information. The Company
shall use its best efforts to prevent the issuance of any such stop order or prevention or suspension of such use. If the Commission
shall enter any such stop order or order or notice of prevention or suspension at any time, the Company will use its best efforts to
obtain the lifting of such order at the earliest possible moment, or will file a new registration statement and use its best efforts
to have such new registration statement declared effective as soon as practicable. Additionally, the Company agrees that it shall comply
with the provisions of Rules 424(b), 430A, 430B and 430C, as applicable, under the Securities Act, including with respect to the timely
filing of documents thereunder, and will use its reasonable efforts to confirm that any filings made by the Company under such Rule 424(b)
are received in a timely manner by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Blue Sky Compliance</U>. The Company will cooperate with the Placement Agents and the Investors in endeavoring to qualify the Securities
for sale under the securities laws of such jurisdictions (United States and foreign) as the Placement Agents and the Investors may reasonably
request and will make such applications, file such documents, and furnish such information as may be reasonably required for that purpose,
provided the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in
any jurisdiction where it is not now so qualified or required to file such a consent, and provided further that the Company shall not
be required to produce any new disclosure document. The Company will, from time to time, prepare and file such statements, reports and
other documents as are or may be required to continue such qualifications in effect for so long a period as the Placement Agents may
reasonably request for distribution of the Securities. The Company will advise the Placement Agents promptly of the suspension of the
qualification or registration of (or any such exemption relating to) the Securities for offering, sale or trading in any jurisdiction
or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification,
registration or exemption, the Company shall use its best efforts to obtain the withdrawal thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Amendments and Supplements to a Prospectus and Other Matters</U>. The Company will comply with the Securities Act and the Exchange
Act, and the rules and regulations of the Commission thereunder, so as to permit the completion of the distribution of the Securities
as contemplated in this Agreement, the Incorporated Documents and any Prospectus. If during the period in which a prospectus is required
by law to be delivered in connection with the distribution of Securities contemplated by the Incorporated Documents or any Prospectus
(the &ldquo;Prospectus Delivery Period&rdquo;), any event shall occur as a result of which, in the judgment of the Company or in the
opinion of the Placement Agent or counsel for the Placement Agent, it becomes necessary to amend or supplement the Incorporated Documents
or any Prospectus in order to make the statements therein, in the light of the circumstances under which they were made, as the case
may be, not misleading, or if it is necessary at any time to amend or supplement the Incorporated Documents or any Prospectus or to file
under the Exchange Act any Incorporated Document to comply with any law, the Company will promptly prepare and file with the Commission,
and furnish at its own expense to the Placement Agent and to dealers, an appropriate amendment to the Registration Statement or supplement
to the Registration Statement, the Incorporated Documents or any Prospectus that is necessary in order to make the statements in the
Incorporated Documents and any Prospectus as so amended or supplemented, in the light of the circumstances under which they were made,
as the case may be, not misleading, or so that the Registration Statement, the Incorporated Documents or any Prospectus, as so amended
or supplemented, will comply with law. Before amending the Registration Statement or supplementing the Incorporated Documents or any
Prospectus in connection with the Offering, the Company will furnish the Placement Agent with a copy of such proposed amendment or supplement
and will not file any such amendment or supplement to which the Placement Agent reasonably objects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Copies of any Amendments and Supplements to a Prospectus</U>. The Company will furnish the Placement Agent, without charge, during
the period beginning on the date hereof and ending on the later of the last Closing Date of the Offering, as many electronic copies of
any Prospectus or prospectus supplement and any amendments and supplements thereto, as the Placement Agent may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Free Writing Prospectus</U>. The Company covenants that it will not, unless it obtains the prior written consent of the Placement
Agent, make any offer relating to the Securities that would constitute a Company Free Writing Prospectus or that would otherwise constitute
a &ldquo;free writing prospectus&rdquo; (as defined in Rule 405 of the Securities Act) required to be filed by the Company with the Commission
or retained by the Company under Rule 433 of the Securities Act. In the event that the Placement Agent expressly consents in writing
to any such free writing prospectus (a &ldquo;Permitted Free Writing Prospectus&rdquo;), the Company covenants that it shall (i) treat
each Permitted Free Writing Prospectus as an Company Free Writing Prospectus, and (ii) comply with the requirements of Rule 164 and 433
of the Securities Act applicable to such Permitted Free Writing Prospectus, including in respect of timely filing with the Commission,
legending and record keeping.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Transfer Agent</U>. The Company will maintain, at its expense, a registrar and transfer agent for the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Additional Documents</U><I>.</I> The Company will enter into any subscription, purchase or other customary agreements as the Placement
Agents or the Investors deem reasonably necessary to consummate the Offering, all of which will be in form and substance reasonably acceptable
to the Placement Agents, the Company and the Investors. The Company agrees that the Placement Agents may rely upon, and each is a third
party beneficiary of, the representations and warranties, and applicable covenants, set forth in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>No Manipulation of Price</U><I>. </I>The Company will not take, directly or indirectly, any action designed to cause or result in,
or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Acknowledgment</U>. The Company acknowledges that any advice given by the Placement Agents to the Company is solely for the benefit
and use of the Board of Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement
Agents&rsquo; prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Announcement of Offering</U>. The Company acknowledges and agrees that the Placement Agents may, subsequent to the Closing, make public
their involvement with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Reliance on Others</U>. The Company confirms that it will rely on its own counsel and accountants for legal and accounting advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Research Matters</U><FONT STYLE="font-variant: small-caps">.</FONT> By entering into this Agreement, the Placement Agents do not provide
any promise, either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges
and agrees that the Placement Agents&rsquo; selection as placement agents for the Offering was in no way conditioned, explicitly or implicitly,
on the Placement Agents providing favorable or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties
acknowledge and agree that the Placement Agents have not directly or indirectly offered favorable research, a specific rating or a specific
price target, or threatened to change research, a rating or a price target, to the Company or inducement for the receipt of business
or compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5. Conditions of the Obligations of the Placement Agents</B>. The obligations of the Placement Agents hereunder shall be subject to the
accuracy of the representations and warranties on the part of the Company set forth in Section 2 hereof, in each case as of the date
hereof and as of each Closing Date as though then made, to the timely performance by each of the Company of its covenants and other obligations
hereunder on and as of such dates, and to each of the following additional conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Accountants&rsquo; Comfort Letter</U>. On the date hereof, the Placement Agent shall have received, and the Company shall have caused
to be delivered to the Placement Agent, a letter from Marcum LLP (the independent registered public accounting firm of the Company),
addressed to the Placement Agent, dated as of the date hereof, in form and substance satisfactory to the Placement Agent. The letter
shall not disclose any change in the condition (financial or other), earnings, operations, business or prospects of the Company from
that set forth in the Incorporated Documents or the applicable Prospectus or prospectus supplement, which, in the Placement Agent&rsquo;s
sole judgment, is material and adverse and that makes it, in the Placement Agent&rsquo;s sole judgment, impracticable or inadvisable
to proceed with the Offering of the Securities as contemplated by such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Compliance with Registration Requirements; No Stop Order; No Objection from the FINRA. Each Prospectus (in accordance with Rule 424(b))
and &ldquo;free writing prospectus&rdquo; (as defined in Rule 405 of the Securities Act), if any, shall have been duly filed with the
Commission, as appropriate; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been
issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; no order preventing or suspending
the use of any Prospectus shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission;
no order having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company shall have
been issued by any securities commission, securities regulatory authority or stock exchange and no proceedings for that purpose shall
have been instituted or shall be pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange; all requests for additional information on the part of the Commission shall have been complied with; and
the FINRA shall have raised no objection to the fairness and reasonableness of the placement terms and arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Corporate Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement
and each Prospectus, and the registration, sale and delivery of the Securities, shall have been completed or resolved in a manner reasonably
satisfactory to the Placement Agents&rsquo; counsel, and such counsel shall have been furnished with such papers and information as it
may reasonably have requested to enable such counsel to pass upon the matters referred to in this Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Material Adverse Effect</U>. Subsequent to the execution and delivery of this Agreement and prior to each Closing Date, in the
Placement Agents&rsquo; sole judgment after consultation with the Company, there shall not have occurred any Material Adverse Effect
or any material adverse change or development involving a prospective material adverse change in the condition or the business activities,
financial or otherwise, of the Company from the latest dates as of which such condition is set forth in the Registration Statement and
Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Opinion of Counsel for the Company</U>. The Placement Agents shall have received on each Closing Date the favorable opinion of US
legal counsel to the Company, dated as of such Closing Date, including, without limitation, a negative assurance letter addressed to
the Placement Agents, in form and substance reasonably satisfactory to Company Counsel and the Placement Agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Officers&rsquo; Certificate</U>. The Placement Agents shall have received on each Closing Date a certificate of the Company, dated
as of such Closing Date, signed by the Chief Executive Officer and Chief Financial Officer of the Company, to the effect that, and the
Placement Agents shall be satisfied that, the signers of such certificate have reviewed the Registration Statement, the Incorporated
Documents, the Prospectus, and this Agreement and the Transaction Documents and to the further effect that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The representations and warranties of the Company in this Agreement are true and correct, as if made on and as of such Closing Date,
and the Company has complied in all material respects with all the agreements and satisfied all the conditions on its part to be performed
or satisfied at or prior to such Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
No stop order suspending the effectiveness of the Registration Statement or the use of any Prospectus has been issued and no proceedings
for that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities Act; no order
having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company has been issued
by any securities commission, securities regulatory authority or stock exchange in the United States and no proceedings for that purpose
have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange in the United States;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
When the Registration Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such
certificate, the Registration Statement and the Incorporated Documents, if any, when such documents became effective or were filed with
the Commission, and any Prospectus, contained all material information required to be included therein by the Securities Act and the
Exchange Act and the applicable rules and regulations of the Commission thereunder, as the case may be, and in all material respects
conformed to the requirements of the Securities Act and the Exchange Act and the applicable rules and regulations of the Commission thereunder,
as the case may be, and the Registration Statement and the Incorporated Documents, if any, and any Prospectus, did not and do not include
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading (provided, however, that the preceding representations
and warranties contained in this paragraph (iii) shall not apply to any statements or omissions made in reliance upon and in conformity
with information furnished in writing to the Company by the Placement Agent expressly for use therein) and, since the effective date
of the Registration Statement, there has occurred no event required by the Securities Act and the rules and regulations of the Commission
thereunder to be set forth in the Incorporated Documents which has not been so set forth; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Subsequent to the respective dates as of which information is given in the Registration Statement, the Incorporated Documents and any
Prospectus, there has not been: (a) any Material Adverse Change; (b) any transaction that is material to the Company and the Subsidiaries
taken as a whole, except transactions entered into in the ordinary course of business; (c) any obligation, direct or contingent, that
is material to the Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred
in the ordinary course of business; (d) any material change in the capital stock (except changes thereto resulting from the exercise
of outstanding stock options or warrants) or outstanding indebtedness of the Company or any Subsidiary; (e) any dividend or distribution
of any kind declared, paid or made on the capital stock of the Company; or (f) any loss or damage (whether or not insured) to the property
of the Company or any Subsidiary which has been sustained or will have been sustained which has a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Bring-down Comfort Letter</U>. On each Closing Date, the Placement Agent shall have received from Marcum LLP, or such other independent
registered public accounting firm of the Company, a letter dated as of such Closing Date, in form and substance satisfactory to the Placement
Agent, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (a) of this Section 5, except
that the specified date referred to therein for the carrying out of procedures shall be no more than three business days prior to such
Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Lock-Up Agreements</U>. On the date hereof, the Placement Agents shall have received the executed lock-up agreement, in the form attached
hereto as <U>Exhibit A</U>, from each of the directors and officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Stock Exchange Listing</U>. The Common Stock shall be registered under the Exchange Act and shall be listed on the Trading Market,
and the Company shall not have taken any action designed to terminate, or likely to have the effect of terminating, the registration
of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market, nor shall
the Company have received any new information suggesting that the Commission or the Trading Market is contemplating terminating such
registration or listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Additional Documents</U>. On or before each Closing Date, the Placement Agents and counsel for the Placement Agents shall have received
such information and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of
the Securities as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction
of any of the conditions or agreements, herein contained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any condition specified in this Section 5 is not satisfied when and as required to be satisfied, this Agreement may be terminated by
the Placement Agents by notice to the Company at any time on or prior to a Closing Date, which termination shall be without liability
on the part of any party to any other party, except that Section 6 (Payment of Expenses), Section 7 (Indemnification and Contribution)
and Section 8 (Representations and Indemnities to Survive Delivery) shall at all times be effective and shall survive such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6. Payment of Expenses</B>. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance
of its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses
incident to the issuance, delivery and qualification of the Securities; (ii) all fees and expenses of the registrar and transfer agent
of the Common Stock; (iii) all necessary issue, transfer and other stamp taxes in connection with the issuance and sale of the Securities;
(iv) all fees and expenses of the Company&rsquo;s counsel, independent public or certified public accountants and other advisors; (v)
all costs and expenses incurred in connection with the preparation, filing, shipping and distribution of the Registration Statement (including
financial statements, exhibits, schedules, consents and certificates of experts), the Base Prospectus, the Final Prospectus and all amendments
and supplements thereto, and this Agreement; (vi) all filing fees, reasonable attorneys&rsquo; fees and expenses incurred by the Company
in connection with qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the
Securities for offer and sale under the state securities or blue sky laws or the securities laws of any other country, and, if requested
by the Placement Agents, preparing and printing a &ldquo;<U>Blue Sky Survey</U>,&rdquo; an &ldquo;<U>International Blue Sky Survey</U>&rdquo;
or other memorandum, and any supplements thereto, advising the Placement Agents of such qualifications, registrations and exemptions;
(vii) if applicable, the filing fees incident to the review and approval by the FINRA of the Placement Agents&rsquo; participation in
the offering and distribution of the Securities; (viii) the fees and expenses associated with including the Securities on the Trading
Market; (ix) all costs and expenses incident to the travel and accommodation of the Company&rsquo;s and the Placement Agents&rsquo; employees
on the &ldquo;<U>roadshow</U>,&rdquo; if any and (x) all other fees, costs and expenses referred to in Part II of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7. Indemnification and Contribution</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company agrees to indemnify and hold harmless the Placement Agents, their respective affiliates and each person controlling the Placement
Agents (within the meaning of Section 15 of the Securities Act), and the directors, officers, agents and employees of the Placement Agents,
their respective affiliates and each such controlling person (the Placement Agents, and each such entity or person. an &ldquo;<U>Indemnified
Person</U>&rdquo;) from and against any losses, claims, damages, judgments, assessments, costs and other liabilities (collectively, the
&ldquo;<U>Liabilities</U>&rdquo;), and shall reimburse each Indemnified Person for all fees and expenses (including the reasonable fees
and expenses of one counsel for all Indemnified Persons, except as otherwise expressly provided herein) (collectively, the &ldquo;<U>Expenses</U>&rdquo;)
as they are incurred by an Indemnified Person in investigating, preparing, pursuing or defending any Actions, whether or not any Indemnified
Person is a party thereto, (i) caused by, or arising out of or in connection with, any untrue statement or alleged untrue statement of
a material fact contained in the Registration Statement, any Incorporated Document, or any Prospectus or by any omission or alleged omission
to state therein a material fact necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading (other than untrue statements or alleged untrue statements in, or omissions or alleged omissions from, information relating
to an Indemnified Person furnished in writing by or on behalf of such Indemnified Person expressly for use in the Incorporated Documents)
or (ii) otherwise arising out of or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant
to this Agreement, the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any
such advice, services or transactions; <U>provided, however</U>, that, in the case of clause (ii) only, the Company shall not be responsible
for any Liabilities or Expenses of any Indemnified Person that are determined to have resulted from such Indemnified Person&rsquo;s (x)
gross negligence or willful misconduct in connection with any of the advice, actions, inactions or services referred to above or (y)
use of any offering materials or information concerning the Company in connection with the offer or sale of the Securities in the Offering
which were not authorized for such use by the Company and which use constitutes gross negligence or willful misconduct. The Company also
agrees to reimburse each Indemnified Person for all Expenses as they are incurred in connection with enforcing such Indemnified Person&rsquo;s
rights under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Upon receipt by an Indemnified Person of actual notice of an Action against such Indemnified Person with respect to which indemnity may
be sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; provided that failure by any Indemnified
Person so to notify the Company shall not relieve the Company from any liability which the Company may have on account of this indemnity
or otherwise to such Indemnified Person, except to the extent the Company shall have been prejudiced by such failure. The Company shall,
if requested by the Placement Agents, assume the defense of any such Action including the employment of counsel reasonably satisfactory
to the Placement Agents, which counsel may also be counsel to the Company. Any Indemnified Person shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Indemnified Person unless: (i) the Company has failed promptly to assume the defense and employ counsel or (ii) the named parties
to any such Action (including any impeded parties) include such Indemnified Person and the Company, and such Indemnified Person shall
have been advised in the reasonable opinion of counsel that there is an actual conflict of interest that prevents the counsel selected
by the Company from representing both the Company (or another client of such counsel) and any Indemnified Person; provided that the Company
shall not in such event be responsible hereunder for the fees and expenses of more than one firm of separate counsel for all Indemnified
Persons in connection with any Action or related Actions, in addition to any local counsel. The Company shall not be liable for any settlement
of any Action effected without its written consent (which shall not be unreasonably withheld). In addition, the Company shall not, without
the prior written consent of the Placement Agents (which shall not be unreasonably withheld), settle, compromise or consent to the entry
of any judgment in or otherwise seek to terminate any pending or threatened Action in respect of which indemnification or contribution
may be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise, consent or termination
includes an unconditional release of each Indemnified Person from all Liabilities arising out of such Action for which indemnification
or contribution may be sought hereunder. The indemnification required hereby shall be made by periodic payments of the amount thereof
during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is due and payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
In the event that the foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the Company
shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect
(i) the relative benefits to the Company, on the one hand, and to the Placement Agents and any other Indemnified Person, on the other
hand, of the matters contemplated by this Agreement or (ii) if the allocation provided by the immediately preceding clause is not permitted
by applicable law, not only such relative benefits but also the relative fault of the Company, on the one hand, and the Placement Agents
and any other Indemnified Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate,
as well as any other relevant equitable considerations; provided that in no event shall the Company contribute less than the amount necessary
to ensure that all Indemnified Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of
fees actually received by the Placement Agents pursuant to this Agreement. For purposes of this paragraph, the relative benefits to the
Company, on the one hand, and to the Placement Agents on the other hand, of the matters contemplated by this Agreement shall be deemed
to be in the same proportion as (a) the total value paid or contemplated to be paid to or received or contemplated to be received by
the Company in the transaction or transactions that are within the scope of this Agreement, whether or not any such transaction is consummated,
bears to (b) the fees paid to the Placement Agents under this Agreement. Notwithstanding the above, no person guilty of fraudulent misrepresentation
within the meaning of Section 11(f) of the Securities Act, as amended, shall be entitled to contribution from a party who was not guilty
of fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise)
to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement,
the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services
or transactions except for Liabilities (and related Expenses) of the Company that are finally judicially determined to have resulted
solely from such Indemnified Person&rsquo;s gross negligence or willful misconduct in connection with any such advice, actions, inactions
or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The reimbursement, indemnity and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement
and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified Person&rsquo;s services
under or in connection with, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8. Representations and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other
statements of the Company or any person controlling the Company, of its officers, and of the Placement Agents set forth in or made pursuant
to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Placement Agents,
the Company, or any of its or their partners, officers or directors or any controlling person, as the case may be, and will survive delivery
of and payment for the Securities sold hereunder and any termination of this Agreement. A successor to a Placement Agents, or to the
Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution
and reimbursement agreements contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9. Notices</B>. All communications hereunder shall be in writing and shall be mailed, hand delivered or e-mailed and confirmed to the
parties hereto as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Roth to the address set forth above, attention: Head of Capital Markets, email: ecm@roth.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Northland to the address set forth above, attention: Jeff Peterson, email: JeffPeterson@northlandcapitalmarkets.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy to: </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ellenoff
Grossman &amp; Schole LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1345
Avenue of the Americas, 11th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10105</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
capmkts@egsllp.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STRYVE
FOODS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
R. Alex Hawkins</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post
Office Box 864</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frisco,
TX 75034</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy to: </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foley
&amp; Lardner LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021
McKinney Avenue Suite 1600</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dallas,
TX 75201</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Christopher Babcock</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
party hereto may change the address for receipt of communications by giving written notice to the others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10. Successors</B>. This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees,
officers and directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and personal representative,
and no other person will have any right or obligation hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
11. Partial Unenforceability</B>. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not
affect the validity or enforceability of any other section, paragraph or provision hereof. If any Section, paragraph or provision of
this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and
only such minor changes) as are necessary to make it valid and enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
12. Governing Law Provisions</B>. This Agreement shall be deemed to have been made and delivered in New York City and both this engagement
letter and the transactions contemplated hereby shall be governed as to validity, interpretation, construction, effect and in all other
respects by the internal laws of the State of New York, without regard to the conflict of laws principles thereof. Each of the Placement
Agents and the Company: (i) agrees that any legal suit, action or proceeding arising out of or relating to this engagement letter and/or
the transactions contemplated hereby shall be instituted exclusively in New York Supreme Court, County of New York, or in the United
States District Court for the Southern District of New York, (ii) waives any objection which it may have or hereafter to the venue of
any such suit, action or proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New
York, and the United States District Court for the Southern District of New York in any such suit, action or proceeding. Each of the
Placement Agents and the Company further agrees to accept and acknowledge service of any and all process which may be served in any such
suit, action or proceeding in the New York Supreme Court, County of New York, or in the United States District Court for the Southern
District of New York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address shall
be deemed in every respect effective service of process upon the Company, in any such suit, action or proceeding, and service of process
upon the Placement Agents mailed by certified mail to the Placement Agent&rsquo;s respective address shall be deemed in every respect
effective service process upon the respective Placement Agents, in any such suit, action or proceeding. Notwithstanding any provision
of this engagement letter to the contrary, the Company agrees that neither the Placement Agents nor its respective affiliates, and the
respective officers, directors, employees, agents and representatives of the Placement Agents, its respective affiliates and each other
person, if any, controlling the Placement Agents or any of its respective affiliates, shall have any liability (whether direct or indirect,
in contract or tort or otherwise) to the Company for or in connection with the engagement and transaction described herein except for
any such liability for losses, claims, damages or liabilities incurred by us that are finally judicially determined to have resulted
from the willful misconduct or gross negligence of such individuals or entities. If either party shall commence an action or proceeding
to enforce any provision of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party
for its reasonable attorney&rsquo;s fees and other costs and expenses incurred with the investigation, preparation and prosecution of
such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
13. General Provisions</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the subject matter hereof. Notwithstanding anything herein to the contrary,
the Engagement Agreement, dated August 1, 2024, as amended September 30, 2024, and October 11, 2024 (collectively, the &ldquo;<U>Engagement
Agreement</U>&rdquo;) by and between the Company and Roth shall continue to be effective and the terms therein shall continue to survive
and be enforceable by Roth in accordance with its terms, including the provisions as set forth in Section 2 of the Engagement Agreement;
provided that, in the event of a conflict between the terms of the Engagement Agreement and this Agreement, the terms of this Agreement
shall prevail. This Agreement may be executed in two or more counterparts, each one of which shall be an original, with the same effect
as if the signatures thereto and hereto were upon the same instrument. This Agreement may not be amended or modified unless in writing
by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party whom
the condition is meant to benefit. Section headings herein are for the convenience of the parties only and shall not affect the construction
or interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company acknowledges that in connection with the offering of the Securities: (i) the Placement Agents have acted at arms length,
are not agents of, and owe no fiduciary duties to the Company or any other person, (ii) the Placement Agents owe the Company only those
duties and obligations set forth in this Agreement and (iii) the Placement Agents may have interests that differ from those of the Company.
The Company waives to the full extent permitted by applicable law any claims it may have against the Placement Agents arising from an
alleged breach of fiduciary duty in connection with the offering of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>The
remainder of this page has been intentionally left blank.</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing is in accordance with your understanding of our agreement, please sign below whereupon this instrument, along with all
counterparts hereof, shall become a binding agreement in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours, </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Stryve
    Foods, Inc.</B>,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    company incorporated under the laws of Delaware</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing Placement Agency Agreement is hereby confirmed and accepted as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Roth
    Capital Partners, LLC</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Northland
    Securities, Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>ex4-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>stryve
foods, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 529,412</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original
    Issue Date: January 11, 2022</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    Issue Date: November 12, 2024</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Armistice Capital Master Fund Ltd.
or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date of receipt of Stockholder Approval, as defined in the Securities Purchase Agreement
with the Company dated November 8, 2024, by and between the Company and the Holder (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and
on or prior to 5:00 p.m. (New York City time) on November 12, 2029 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to
subscribe for and purchase from Stryve Foods, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 529,412 shares (as
subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common
Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated January 6, 2022, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States
bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the
date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a
portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. Notwithstanding the foregoing, with respect to any Notice(s)
of Exercise delivered on or prior to 4:00 p.m. (New York City time) on the Trading Date prior to the Initial Exercise Date, which may
be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share
Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received by such Warrant Share Delivery Date. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>0.79, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either
(y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common
Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a
Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date
until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant
in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to
the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than
50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making
or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this
Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation,
and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor
Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the
consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of
Directors, Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and
in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the
holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash,
stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms
of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock of
the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to
have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental
Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model
obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction
for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time
between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility
equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as
of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price
per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the
value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the average VWAP during the ten-day
period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier) and (D) a remaining option time equal to the time between the date of the public
announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black
Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five
Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause
any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with
the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the
Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to
any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the
other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at
its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for
the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to
the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>stryve
    foods, inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">stryve
    foods, inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:_______________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of November 8, 2024, between Stryve Foods, Inc., a company
incorporated under the laws of Delaware (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto
(each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires
to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.<BR>
DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York are generally open for use by customers on such day</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first (1st) Trading
Day following the date hereof (or the second (2<SUP>nd</SUP>) Trading Day following the date hereof if this Agreement is signed on a
day that is not a Trading Day or after 4:00 p.m. (New York City time) and before midnight (New York City time) on a Trading Day).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Class A common stock of the Company, par value $0.0001 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrants</U>&rdquo; means the Common Stock purchase warrants delivered to the Purchasers in accordance with Section 2.2 hereof, which
Common Warrants shall be exercisable at any time on or after the date that the Stockholder Approval is obtained and deemed effective,
and shall have a term of exercise equal to 5 years from the initial exercise date, in the form of <U>Exhibit B-1</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Foley &amp; Lardner LLP, with offices located at 1 Independent Dr, Suite 1300, Jacksonville, FL 32202.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agents, and (ii) if this Agreement is signed between
midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on
the date hereof, unless otherwise instructed as to an earlier time by the Placement Agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>EGS</U>&rdquo;
means Ellenoff Grossman &amp; Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105-0302.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers, directors or consultants of the
Company pursuant to any equity incentive plan duly adopted for such purpose by a majority of the non-employee members of the Board of
Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to
the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder, warrants to the Placement
Agent in connection with the transactions pursuant to this Agreement and any securities upon exercise of the warrants to the Placement
Agent, and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the
date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of
such securities or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of such
securities, (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors
of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no
registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period
in Section 4.11(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which
is, itself or through its subsidiaries, an operating company or an owner of an asset in a business believed to be synergistic with the
business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include
a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business
is investing in securities and (d) Common Stock Equivalents issued to the Company&rsquo;s existing noteholders in satisfaction of such
debt; provided such Common Stock Equivalents have an exercise or conversion price in excess of the Common Warrants and may not be converted
into Common Stock for a period of seventy-five (75) days after the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Existing
Warrants</U>&rdquo; means (a) the Common Stock Purchase Warrants issued on January 11, 2022 to each of the Purchasers who are party to
this Agreement, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
means (a) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the
ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others,
whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c)
the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the Company&rsquo;s officers
and directors, in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; means (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii)
a material adverse effect on the results of operations, assets, business or condition (financial or otherwise) of the Company and the
Subsidiaries, taken as a whole or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on
a timely basis its obligations under any Transaction Document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $0.79, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agents</U>&rdquo; means Roth Capital Partners, LLC and Northland Securities, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preliminary
Prospectus</U>&rdquo; means any preliminary prospectus included in the Registration Statement, as originally filed or as part of any
amendment thereto, or filed with the Commission pursuant to Rule 424(b) of the rules and regulations of the Commission under the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pricing
Prospectus</U>&rdquo; means (i) the Preliminary Prospectus relating to the Securities that was included in the Registration Statement
immediately prior to 9:00 a.m. (New York City time) on the date hereof and (ii) any free writing prospectus (as defined in the Securities
Act)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means the Pre-Funded Common Stock purchase warrants delivered to the Purchasers in accordance with Section 2.2 hereof,
which Pre-Funded Warrants shall be exercisable immediately and shall be exercisable until exercised in full, in the form of <U>Exhibit
B-2</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission file No. 333-282043 which registers the sale of the Shares,
the Warrants and the Warrant Shares to the Purchasers, and includes any Rule 462(b) Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
462(b) Registration Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Securities,
which was filed with the Commission on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated
by the Commission pursuant to the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Stockholder
Approval&rdquo; means such approval as may be required by the applicable rules and regulations of the NASDAQ Capital Market (or any successor
entity) from the stockholders of the Company to permit the exercise of the Common Warrants and Existing Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: blue"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the
Pre-Funded Warrants purchased by such Purchaser, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Lock-Up Agreement, all exhibits and schedules thereto and hereto and any
other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with offices located at 1
State St 30th floor, New York, NY 10004, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.11(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB Venture Market (&ldquo;OTCQB&rdquo;) or OTCQX Best Market
(&ldquo;OTCQX&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported on the Pink Open Market (&ldquo;Pink Market&rdquo;) operated by OTC Markets, Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and Pre-funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.<BR>
PURCHASE AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the
Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $2,900,000 of Shares and Warrants. Notwithstanding anything
herein to the contrary, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser&rsquo;s Subscription Amount
(together with such Purchaser&rsquo;s Affiliates and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s
Affiliates) would cause such Purchaser&rsquo;s beneficial ownership of the shares of Common Stock to exceed the Beneficial Ownership
Limitation, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of the Shares as determined pursuant to Section 2.2(a).
The &ldquo;Beneficial Ownership Limitation&rdquo; shall be 4.99% (or, at the election of the Purchaser at Closing, 9.99%) of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date. In each
case, the election to receive Pre-Funded Warrants is solely at the option of the Purchaser. Each Purchaser shall deliver to the Company,
via wire transfer, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page
hereto executed by such Purchaser, and the Company shall deliver to each Purchaser its respective Shares and Common Warrants, and any
Pre-Funded Warrants, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth
in Section 2.2 deliverable at the Closing. Upon satisfaction (or waiver) of the covenants and conditions set forth in Sections 2.2 and
2.3, the Closing shall occur at the offices of EGS or such other location (including remotely by electronic transmission) as the parties
shall mutually agree. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &ldquo;Delivery Versus
Payment&rdquo; (&ldquo;DVP&rdquo;) (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo;
names and addresses and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser;
upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment
therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company). Notwithstanding anything herein
to the contrary, if at any time on or after the time of execution of this Agreement by the Company and an applicable Purchaser, through,
and including the time immediately prior to the Closing (the &ldquo;Pre-Settlement Period&rdquo;), such Purchaser sells to any Person
all, or any portion, of the Shares to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;Pre-Settlement Shares&rdquo;),
such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to
be unconditionally bound to purchase, such Pre-Settlement Shares at the Closing; provided, that the Company shall not be required to
deliver any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement
Shares hereunder; and provided further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation
or covenant by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock
to any Person and that any such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser
elects to effect any such sale, if any. Notwithstanding anything to the contrary herein and a Purchaser&rsquo;s Subscription Amount set
forth on the signature pages attached hereto, the number of Shares purchased by a Purchaser (and its Affiliates) hereunder shall not,
when aggregated with all other shares of Common Stock owned by such Purchaser (and its Affiliates) at such time, result in such Purchaser
beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act) in excess of 4.99/9.99% of the then issued and
outstanding Common Stock outstanding at the Closing (the &ldquo;Beneficial Ownership Maximum&rdquo;), and such Purchaser&rsquo;s Subscription
Amount, to the extent it would otherwise exceed the Beneficial Ownership Maximum immediately prior to the Closing, shall be conditioned
upon the issuance of Shares at the Closing to the other Purchasers signatory hereto. To the extent that a Purchaser&rsquo;s beneficial
ownership of the Shares would otherwise be deemed to exceed the Beneficial Ownership Maximum, such Purchaser&rsquo;s Subscription Amount
shall automatically be reduced as necessary in order to comply with this paragraph. Notwithstanding the foregoing, with respect to any
Notice(s) of Exercise (as defined in the Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Closing Date, which
may be delivered at any time after the time of execution of this Agreement, the Company agrees to deliver the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date
(as defined in the Warrants) for purposes hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel, directed to the Placement Agents, in a form reasonably acceptable to Company Counsel and the Placement
Agents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
subject to Section 2.1, the Company shall have provided the Placement Agent with the Company&rsquo;s wire instructions, on Company letterhead
and executed by the Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
subject to Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an
expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) Shares equal to
such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
a Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 200% of such
Purchaser&rsquo;s Shares, with an exercise price equal to $0.79, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
if applicable, for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such
Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable
to Pre-Funded Warrant divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal to $0.0001;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the
Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
the Lock-Up Agreements, duly executed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
the Pricing Prospectus and the Prospectus (which may be delivered in accordance with Rule 172 under the Securities Act) and.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
as applicable, for each Purchaser pursuant to Section 4.18, the amended and restated Existing Warrants registered in the name of such
Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the
Company or its designee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects)
on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in
which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality,
in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.<BR>
REPRESENTATIONS AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. The Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect significant Subsidiaries of the Company are set forth in the SEC Reports. The Except
for Class B common units of Andina Holdings, LLC, the Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary
are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.
If the Company has no Subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would
not have or reasonably be expected to result in a Material Adverse Effect and no Proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents to which the Company is a party and otherwise to carry out
its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by
the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary
action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders
in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document
to which the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance
with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws
relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as would not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filing
with the Commission of the Prospectus (ii) the Stockholder Approval, and (iii) such filings as are required to be made under applicable
state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with
the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed
by the Company. The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and
nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the
maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the
Registration Statement in conformity with the requirements of the Securities Act, which became effective on November 8, 2024, including
the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration
Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement
or suspending or preventing the use of any Preliminary Prospectus or the Prospectus has been issued by the Commission and no proceedings
for that purpose have been instituted or, to the knowledge of the Company, are threatened in writing by the Commission. The Company,
if required by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b). At
the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date,
the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the
Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to
be stated therein or necessary to make the statements therein not misleading; and the Pricing Prospectus and the Prospectus and any amendments
or supplements thereto, at the time the Pricing Prospectus or the Prospectus, as applicable, or any amendment or supplement thereto was
issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did
not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company is as set forth in the SEC Reports. The Company has not issued any capital stock
since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee equity incentives
under the Company&rsquo;s equity incentive plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s
employee equity incentive plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date
of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right
of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result
of the purchase and sale of the Securities or as set forth in the Registration Statement or SEC Reports, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common
Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or the capital stock of any Subsidiary.
The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities
to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any
provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities
by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any
redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital
stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal
and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to
subscribe for or purchase securities. The authorized shares of the Company conform in all material respects to all statements relating
thereto contained in the Registration Statement and the Prospectus. The offers and sales of the Company&rsquo;s securities were at all
relevant times either registered under the Securities Act and the applicable state securities or Blue Sky laws or, based in part on the
representations and warranties of the purchasers, exempt from such registration requirements. Except for the Required Approvals, no further
approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities.
There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock
to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
one year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus, being
collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such
time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC
Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of
the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have
been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods
involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements
and documents described in the Registration Statement, the Prospectus and the SEC Reports conform in all material respects to the descriptions
thereof contained therein and there are no agreements or other documents required by the Securities Act and the rules and regulations
thereunder to be described in the Registration Statement, the Prospectus or the SEC Reports or to be filed with the Commission as exhibits
to the Registration Statement, that have not been so described or filed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there has, to
the Company&rsquo;s knowledge, been no event, occurrence or development that has had or that could would reasonably be expected to result
in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables
and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be
reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company
has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property
to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock, (v) the Company
has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company equity incentive plans
and (vi) no officer or director of the Company has resigned from any position with the Company. The Company does not have pending before
the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this
Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur
or exist with respect to the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial
condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made
or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.
Unless otherwise disclosed in an SEC Report filed prior to the date hereof, the Company has not: (i) issued any securities or incurred
any material liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other
distribution on or in respect to its capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth in the SEC Report, to the knowledge of the Company, there is no action, suit, inquiry, notice
of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any
Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory
authority (federal, state, county, local or foreign) (collectively, an &ldquo;Action&rdquo;) which (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) would, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which would reasonably be expected to result in a Material Adverse Effect. To the knowledge of the Company, no executive
officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or
any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the
Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are
in compliance in all material respects with all U.S. federal, state, local and foreign laws and regulations relating to employment and
employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other material agreement or instrument to which it is a party or by which it or any of its properties
is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court,
arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any
governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection,
occupational health and safety, product quality and safety and employment and labor matters, except in each case as would not have or
reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. To the Company&rsquo;s knowledge, the Company and its Subsidiaries (i) are in compliance with all applicable
federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air,
surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened
releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;Hazardous Materials&rdquo;)
into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport
or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments,
licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;Environmental
Laws&rdquo;); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct
their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where
in each clause (i), (ii) and (iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate,
a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could would not reasonably be expected to result in a Material Adverse Effect (each,
a &ldquo;Material Permit&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation
or modification of any Material Permit. The disclosures in the Registration Statement concerning the effects of Federal, State, local
and all foreign regulation on the Company&rsquo;s business as currently contemplated are correct in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to, or have valid and marketable
rights to lease or otherwise use, all real property and all personal property that is material to the business of the Company and the
Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and
do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens
for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP, and
the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company
and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are
in compliance in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and except
where failure to do so could would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse
Effect (collectively, the &ldquo;Intellectual Property Rights&rdquo;). None of, and neither the Company nor any Subsidiary has received
a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected
to expire or terminate or be abandoned, within two (2) years from the date of this Agreement, except as would not reasonably be expected
to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial
statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property
Rights violate or infringe upon the rights of any Person. To the knowledge of the Company, all such Intellectual Property Rights are
enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries
have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except
where failure to do so could would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary for companies of a similar size as the Company, in the businesses in which
the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions with Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the Company
or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to
any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from, any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including equity incentive agreements under any equity incentive plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with
any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable
rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The
Company and the Subsidiaries maintain a system of internal accounting controls and the Company and the Subsidiaries have established
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and
designed such disclosure controls and procedures to provide reasonable assurance that information required to be disclosed by the Company
in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified
in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure
controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report
under the Exchange Act (such date, the &ldquo;Evaluation Date&rdquo;). The Company presented in its most recently filed periodic report
under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based
on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial
reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably
likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except as set forth in the Prospectus, no brokerage or finder&rsquo;s fees or commissions are or will be payable
by the Company, any Subsidiary or Affiliate of the Company to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. To the Company&rsquo;s knowledge,
there are no other arrangements, agreements or understandings of the Company or, to the Company&rsquo;s knowledge, any of its stockholders
that may affect the Placement Agents&rsquo; compensation, as determined by FINRA. The Company has not made any direct or indirect payments
(in cash, securities or otherwise) to: (i) any person, as a finder&rsquo;s fee, consulting fee or otherwise, in consideration of such
person raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii) any
FINRA member; or (iii) any person or entity that has any direct or indirect affiliation or association with any FINRA member, within
the twelve months prior to the Execution Date. None of the net proceeds of the Offering will be paid by the Company to any participating
FINRA member or its affiliates, except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Investment Company</U>. The Company is not, and immediately after receipt of payment for the Securities will not be, an &ldquo;investment
company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Registration Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities
Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading
Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing
or maintenance requirements of such Trading Market. The Common Stock is currently eligible for electronic transfer through the Depository
Trust Company or another established clearing corporation and the Company is current in payment of the fees of the Depository Trust Company
(or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable as a result of the Purchasers and the Company fulfilling their
obligations or exercising their rights under the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Disclosure</U>. The Registration Statement (and any further documents filed with the Commission) contains all exhibits and schedules
as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, if any, at the time it
became effective, complied in all material respects with the Securities Act and the applicable rules and regulations under the Securities
Act and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Preliminary Prospectus,
and the Prospectus, each as of its respective date, comply in all material respects with the Securities Act and the applicable rules
and regulations. Each of the Preliminary Prospectus and the Prospectus, as amended or supplemented, did not and will not contain as of
the date thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading. The SEC Reports, when they were filed with the Commission,
conformed in all material respects to the requirements of the Exchange Act and the applicable rules and regulations, and none of such
documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted to state a material
fact necessary to make the statements therein (with respect to the SEC Reports incorporated by reference in the Preliminary Prospectus
or Prospectus), in light of the circumstances under which they were made not misleading; and any further documents so filed and incorporated
by reference in the Preliminary Prospectus, or Prospectus, when such documents are filed with the Commission, will conform in all material
respects to the requirements of the Exchange Act and the applicable rules and regulations, as applicable, and will not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances
under which they were made not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising
after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is
required to be filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction
contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite
time period. There are no contracts or other documents required to be described in the Preliminary Prospectus, or Prospectus, or to be
filed as exhibits or schedules to the Registration Statement, which have not been described or filed as required. The press releases
disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees
that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would reasonably be expected to cause
this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval
provisions of any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, the Company does not believe that the Company&rsquo;s assets
constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital
needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital
requirements and capital availability thereof. The Company does not intend to incur debts beyond its ability to pay such debts as they
mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). Except as set forth in the SEC
Reports, the Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or
liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. The SEC Reports sets
forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company
or any Subsidiary has commitments. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. To the Company&rsquo;s knowledge, there
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
or of any Subsidiary know of no basis for any such claim. The provisions for taxes payable, if any, shown on the financial statements
filed with or as part of the Registration Statement are believed by the Company to be sufficient for all accrued and unpaid taxes, whether
or not disputed, and for all periods to and including the dates of such consolidated financial statements. The term &ldquo;taxes&rdquo;
mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise,
profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property,
windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest and
any penalties, additions to tax, or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means all returns, declarations,
reports, statements, and other documents required to be filed in respect to taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Foreign Corrupt Practices.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Accountants</U>. To the knowledge and belief of the Company, the Company Auditor (i) is an independent registered public accounting
firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the
Company&rsquo;s Annual Report for the fiscal year ending December 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>No Disagreements with Accountants and Lawyers.</U> There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any
of its obligations under any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<FONT STYLE="text-decoration: double">Acknowledgment Regarding Purchaser&rsquo;s Trading Activity. Anything in
this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(g) and 4.13 hereof), it is understood and
acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to
desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities
issued by the Company or to hold the Securities for any specified term, (ii) past or future open market or other transactions by any
Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing
of this or future private placement transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities,
(iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or
indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock and (iv) each Purchaser shall not be deemed to have
any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction. </FONT>The Company
further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period
that the Securities are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable
with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders&rsquo;
equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that
such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Regulation M Compliance.</U> The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agents in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>FINRA Affiliation</U>. To the Company&rsquo;s knowledge, no officer, director or any beneficial owner of 5% or more of the Company&rsquo;s
unregistered securities has any direct or indirect affiliation or association with any FINRA member (as determined in accordance with
the rules and regulations of FINRA) that is participating in the Offering. The Company will advise the Placement Agents and EGS if it
learns that any officer, director or owner of 5% or more of the Company&rsquo;s outstanding shares of Common Stock or Common Stock Equivalents
is or becomes an affiliate or associated person of a FINRA member firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
FDA. As to each product subject to the regulation of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under the Federal
Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured, packaged, labeled,
tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical Product</U>&rdquo;),
such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance
with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket
clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product
listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not
have a Material Adverse Effect. There is no pending, completed or, to the Company&rsquo;s knowledge, threatened, action (including any
lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or
any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication
from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the
uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical
Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising
or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by
the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters
or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges
any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate,
would have a Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all
material respects in accordance with all applicable laws, rules and regulations of the FDA. The Company has not been informed by the
FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced
or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed
or proposed to be developed by the Compan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s equity incentive plan was granted (i) in
accordance with the terms of the Company&rsquo;s equity incentive plan and (ii) with an exercise price at least equal to the fair market
value of the Common Stock on the date such equity incentive would be considered granted under GAAP and applicable law. No stock option
granted under the Company&rsquo;s equity incentive plan has been backdated. The Company has not knowingly granted, and there is no and
has been no Company policy or practice to knowingly grant, equity incentives prior to, or otherwise knowingly coordinate the grant of
equity incentives with, the release or other public announcement of material information regarding the Company or its Subsidiaries or
their financial results or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Cybersecurity</U>. (i)(x) To the Company&rsquo;s knowledge, there has been no material security breach or other compromise of or relating
to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data
(including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of
it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not
been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach
or other material compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance in all material
respect with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental
or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and
to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually
or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially
reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy
and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology
consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Compliance with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years
were, in compliance in all material respects with all applicable state, federal and foreign data privacy and security laws and regulations,
including, without limitation, the European Union General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;) (EU 2016/679) (collectively,
&ldquo;<U>Privacy Laws</U>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably
designed to ensure compliance with their policies and procedures relating to data privacy and security and the collection, storage, use,
disclosure, handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); (iii) the Company provides
accurate notice of its applicable Policies to its customers, employees, third party vendors and representatives as required by the Privacy
Laws; and (iv) applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating
to its subject matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices, as required by
Privacy Laws. &ldquo;<U>Personal Data</U>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address,
photograph, social security number, bank information, or customer or account number; (ii) any information which would qualify as &ldquo;personally
identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR;
and (iv) any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection
or analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures
made or contained in any of the Policies have been inaccurate, misleading, or deceptive in any material respect in violation of any Privacy
Laws and (ii) the execution, delivery and performance of the Transaction Documents will not result in a breach of any Privacy Laws or
Policies. Neither the Company nor the Subsidiaries (i) to the knowledge of the Company, has received written notice of any actual or
potential liability of the Company or the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of,
any of the Privacy Laws; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation or other corrective
action pursuant to any regulatory request or demand pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement
by or with any court or arbitrator or governmental or regulatory authority that imposed any obligation or liability under any Privacy
Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent or employee of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Placement Agents&rsquo;
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries owns or controls, directly or indirectly, five
percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation
by the Federal Reserve</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in material compliance
with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering
Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving
the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary,
threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or
otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the
ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Pre-Funded Warrants, it will be an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither
the Placement Agents nor any Affiliate of the Placement Agents has provided such Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired. Neither the Placement Agents nor any Affiliate has made or
makes any representation as to the Company or the quality of the Securities and the Placement Agents and any Affiliate may have acquired
non-public information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance
of the Securities to such Purchaser, neither the Placement Agents nor any of its Affiliates has acted as a financial advisor or fiduciary
to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
pricing terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warrant Shares</U>. If all or any portion of a Warrant
is exercised at a time when there is an effective registration statement to cover the issuance or resale of the Warrant Shares or if
the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to any such exercise shall be issued free of all legends.
If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering the sale or
resale of the Warrant Shares) is not effective or is not otherwise available for the sale or resale of the Warrant Shares, the Company
shall immediately notify the holders of the Warrants in writing that such registration statement is not then effective and thereafter
shall promptly notify such holders when the registration statement is effective again and available for the sale or resale of the Warrant
Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser to sell,
any of the Warrant Shares in compliance with applicable federal and state securities laws). The Company shall use best efforts to keep
a registration statement (including the Registration Statement) registering the issuance or resale of the Warrant Shares effective during
the term of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information</U>. Until the earliest of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired,
the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports
required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the
reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including,
without limitation, the Placement Agents, in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees, Affiliates or agents, including, without limitation, the Placement Agents, on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and
each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the
prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with
respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is
required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission
and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers
with prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material pricing terms of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall
not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agents, or a duty to the Company, any of its Subsidiaries or any of
their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agents, not to trade
on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant
in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. The Company will apply the net proceeds from the Offering received by it in a manner consistent with the application
described under the caption &ldquo;Use of Proceeds&rdquo; in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;Purchaser Party&rdquo;) harmless from any and all
losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements,
court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result
of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the
transactions contemplated by the Transaction Documents (unless such action is based upon a material breach of such Purchaser Party&rsquo;s
representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may
have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser
Party which constitutes fraud, gross negligence, willful misconduct or malfeasance). If any action shall be brought against any Purchaser
Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company
in writing, and, the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable
to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the
defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that
(i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel a
material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be
liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior
written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim,
damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations and warranties of such Purchaser
Party in this Agreement or any other Transaction Document to which it is a party. The indemnification required by this Section 4.8 shall
be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Listing of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation
of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply
to list or quote all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and
Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other
Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is
necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible.
The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market
and will comply in all material respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of
the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository
Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository
Trust Company or such other established clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Subsequent Equity Sales. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until seventy-five (75) days after the Closing Date, Company nor any Subsidiary shall (i) issue, enter into any
agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file
any registration statement or amendment or supplement thereto, other than the Prospectus Supplement or filing a registration statement
on Form S-8 in connection with any employee benefit plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until six (6) months after the Closing Date, the Company shall be prohibited from effecting or entering into an
agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which
the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include
the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price
that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial
issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some
future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly
or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction
under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the
Company may issue securities at a future determined price regardless of whether shares pursuant to such agreement have actually been
issued and regardless of whether such agreement is subsequently canceled; <U>provided</U>, <U>however</U>, that, after seventy-five (75)
days after the Closing Date, the entry into and/or issuance of shares of Common Stock in an &ldquo;at the market&rdquo; offering with
the Roth Capital Partners, LLC as sales agent shall not be deemed a Variable Rate Transaction. Any Purchaser shall be entitled to obtain
injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of this Agreement) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also offered
to all of the parties to this Agreement. For clarification purposes, this provision constitutes a separate right granted to each Purchaser
by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall
not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of
Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction (other than as disclosed
to its legal and other representatives). N<FONT STYLE="color: windowtext">otwithstanding the foregoing and notwithstanding anything contained
in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty
or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no
Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable
securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade
in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agent, including, without limitation, the Placement Agents after the issuance of the initial press release as described
in Section 4.4. </FONT>Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth
above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Pre-Funded Warrant
Shares pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay
or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of
the dilutive effect that such issuance may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Exercise Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to
exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms,
conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Lock-Up Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except
to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If
any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek
specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Stockholder Approval</U>. The Company shall use its reasonable best efforts hold a special meeting of stockholders on or prior to
sixty (60) days after the Closing date for the purpose of obtaining Stockholder Approval with respect to the terms of the Common Warrants
and Existing Warrants, with the recommendation of the Company&rsquo;s Board of Directors that such proposal is approved, and the Company
shall solicit proxies from its stockholders in connection therewith in the same manner as all other management proposals in such proxy
statement and all management-appointed proxyholders shall vote their proxies in favor of such proposal. If the Company does not obtain
Stockholder Approval with respect to the terms of the Common Warrants and Existing Warrants at the first special meeting of the stockholders,
the Company shall call a meeting every sixty (60) days thereafter to seek such Stockholder Approval until the date on which Stockholder
Approval is obtained or the Common Warrants and Existing Warrants are no longer outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18
<U>Reduction of Exercise Price. </U>The Company irrevocably agrees, effective on the Closing Date, to (i) reduce the exercise price of
the Existing Warrants to equal $0.79 (subject to adjustment therein), pursuant to Section 2(b) of such Existing Warrants and (ii) extend
the term of the Existing Warrants to extend the Termination Date (as defined in the Existing Warrants) to equal the five (5) year anniversary
of the Closing Date, which shall become exercisable upon Stockholder Approval. On the Closing Date, the Company will amend such Existing
Warrants pursuant to this Section 4.18 and shall deliver or cause to be delivered to each applicable Purchaser an amended and restated
Existing Warrant certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.<BR>
MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Pricing Prospectus and the
Prospectus contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such
notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto on
a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading
Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the
party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature
pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Warrants
based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Purchaser (or multiple Purchasers), the consent of such disproportionately impacted Purchaser
(or at least 50.1% in interest of such multiple Purchasers) shall also be required. No waiver of any default with respect to any provision,
condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default
or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right
hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and
adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers
shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section
5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. The Placement Agents shall be the third party beneficiary of the representations, warranties, and
covenants of the Company in this Agreement and the representations, warranties, and covenants of the Purchasers in this Agreement. This
Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section
5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall
be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through EGS. EGS does not represent any of the Purchasers and only represents the Placement Agents. The
Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not
because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained
in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company
and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Stryve
    Foods, Inc..</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice: </U></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STRYVE
    FOODS, INC.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    R. Alex Hawkins</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post
    Office Box 864</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frisco,
    TX 75034</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 62%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foley
    &amp; Lardner LLP</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021
    McKinney Avenue Suite 1600</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dallas,
    TX 75201</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Christopher Babcock</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">SNAX</FONT> SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: __________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: ______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Existing
Warrants:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____
202_ Common Stock Purchase Warrants: <U>______________</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrant Shares: ______________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrant Shares: ______________ Beneficial Ownership Blocker &#9744;  4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: _______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed
to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of
the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded,
(ii) the Closing shall occur on the first (1st) Trading Day following the date of this Agreement(the second (2nd) Trading Day
following the date hereof in the event this Agreement is signed on a day that is not a Trading Day or after 4:01 p.m. (New York City
time) and before midnight (New York City time) on a Trading Day) and (iii) any condition to Closing contemplated by this Agreement
(but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement,
instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an
unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or
the like or purchase price (as applicable) to such other party on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stryve
Foods, Inc. Announces Pricing of $2.9 Million Public Offering Priced At-Market According to Nasdaq Rules</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLANO,
Texas, November 8, 2024 (GLOBE NEWSWIRE) &mdash; Stryve Foods, Inc. (&ldquo;Stryve&rdquo; or &ldquo;the Company&rdquo;) (NASDAQ: SNAX),
an emerging healthy snacking platform and leader in the air-dried meat snack industry in the United States, today announced the pricing
of a public offering priced at-market according to Nasdaq rules of 3,670,886 shares of its Class A common stock and commons stock equivalents
and warrants to purchase up to an aggregate of 7,341,722 shares of its Class A common stock at a combined public offering price of $0.79
per share (or prefunded warrant) and associated common warrants. Each share of Class A common stock (or prefunded warrant) is being sold
together with two warrants each to purchase one share of Class A common stock. The common warrants will have an exercise price of $0.79
per share, are exercisable following stockholder approval and have a term of exercise equal to five years following date of the stockholder
approval. The closing of the offering is expected to occur on or about November 12, 2024, subject to the satisfaction of customary closing
conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, the Company also agreed to amend certain existing warrants to purchase up to 529,412 shares of its Class
A common stock at an exercise price of $54.00 per share to have a reduced exercise price equal to $0.79 per share, subject to stockholder
approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roth
Capital Partners and Northland Capital Markets are acting as the co-placement agents for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross proceeds to the Company from the offering are expected to be $2.9 million, before deducting the placement agents&rsquo; fees and
other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for working capital and
general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities described above are being offered pursuant to the Company&rsquo;s registration statement on Form S-1 (File No. 333-282043)
originally filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) on September 11, 2024, and which became effective on
November 8, 2024. The public offering is being made only by means of a prospectus, which is part of the effective registration statement.
When available, electronic copies of the final prospectus may be obtained for free on the SEC&rsquo;s website located at http://www.sec.gov
and may also be obtained by contacting Roth Capital Partners, LLC at 888 San Clemente Drive, Newport Beach CA 92660 by phone at (800)
678-9147 or e-mail at rothecm@roth.com, or by contacting Northland Capital Markets at 150 South Fifth Street, Suite 3300, Minneapolis,
MN, by telephone: (800) 851-2920, or by email at fjohnson@northlandcapitalmarkets.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of that jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Stryve Foods, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stryve
is a premium air-dried meat snack company that is conquering the intersection of high protein, great taste, and health under the brands
of Braaitime&reg;, Kalahari&reg;, Stryve&reg;, and Vacadillos&reg;. Stryve sells highly differentiated healthy snacking and food products
in order to disrupt traditional snacking and CPG categories. Stryve&rsquo;s mission is &ldquo;to help Americans eat better and live happier,
better lives.&rdquo; Stryve offers convenient products that are lower in sugar and carbohydrates and higher in protein than other snacks
and foods. Stryve&rsquo;s current product portfolio consists primarily of air-dried meat snack products marketed under the Stryve&reg;,
Kalahari&reg;, Braaitime&reg;, and Vacadillos&reg; brand names. Unlike beef jerky, Stryve&rsquo;s all-natural air-dried meat snack products
are made of beef and spices, are never cooked, contain zero grams of sugar*, and are free of monosodium glutamate (MSG), gluten, nitrates,
nitrites, and preservatives. As a result, Stryve&rsquo;s products are Keto and Paleo diet friendly. Further, based on protein density
and sugar content, Stryve believes that its air-dried meat snack products are some of the healthiest shelf-stable snacks available today.
Stryve also markets and sells human-grade pet treats under the brands Two Tails and Primal Paws, made with simple, all-natural ingredients
and 100% real beef with no fillers, preservatives, or by-products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stryve
distributes its products in major retail channels, primarily in North America, including grocery, convenience store, mass merchants,
and other retail outlets, as well as directly to consumers through its ecommerce websites and through the Amazon and Wal*mart platforms.
For more information about Stryve, visit www.stryve.com or follow us on social media at @stryvebiltong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
All Stryve Biltong and Vacadillos products contain zero grams of added sugar, with the exception of the Chipotle Honey flavor of Vacadillos,
which contains one gram of sugar per serving.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cautionary
Note Regarding Forward-Looking Statements.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements made herein are &ldquo;forward-looking statements&rdquo; within the meaning of the &ldquo;safe harbor&rdquo; provisions of
the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as &ldquo;anticipate&rdquo;,
&ldquo;may&rdquo;, &ldquo;will&rdquo;, &ldquo;would&rdquo;, &ldquo;could&rdquo;, &ldquo;intend&rdquo;, &ldquo;aim&rdquo;, &ldquo;believe&rdquo;,
&ldquo;anticipate&rdquo;, &ldquo;continue&rdquo;, &ldquo;target&rdquo;, &ldquo;milestone&rdquo;, &ldquo;expect&rdquo;, &ldquo;estimate&rdquo;,
&ldquo;plan&rdquo;, &ldquo;outlook&rdquo;, &ldquo;objective&rdquo;, &ldquo;guidance&rdquo; and &ldquo;project&rdquo; and other similar
expressions that predict or indicate future events or trends or that are not statements of historical matters, including, but not limited
to, statements regarding Stryve&rsquo;s plans, strategies, objectives, targets and expected financial performance. These forward-looking
statements reflect Stryve&rsquo;s current views and analysis of information currently available. This information is, where applicable,
based on estimates, assumptions and analysis that Stryve believes, as of the date hereof, provide a reasonable basis for the information
and statements contained herein. These forward-looking statements involve various known and unknown risks, uncertainties and other factors,
many of which are outside the control of Stryve and its officers, employees, agents and associates. These risks, uncertainties, assumptions
and other important factors, which could cause actual results to differ materially from those described in these forward-looking statements,
include: (i) the completion of the public offering and the satisfaction of customary closing conditions related to the public offering
and the intended use of proceeds from the public offering, (ii) the inability to achieve profitability due to commodity prices, inflation,
supply chain interruption, transportation costs and/or labor shortages; (iii) the ability to recognize the anticipated benefits of the
Business Combination or meet financial and strategic goals, which may be affected by, among other things, competition, supply chain interruptions,
the ability to pursue a growth strategy and manage growth profitability, maintain relationships with customers, suppliers and retailers
and retain its management and key employees; (iv) the risk that retailers will choose to limit or decrease the number of retail locations
in which Stryve&rsquo;s products are carried or will choose not to carry or not to continue to carry Stryve&rsquo;s products; (v) the
possibility that Stryve may be adversely affected by other economic, business, and/or competitive factors; (vi) the effect of the COVID-19
pandemic on Stryve; (vii) the possibility that Stryve may not achieve its financial outlook; (viii) risks around the Company&rsquo;s
ability to continue as a going concern and (ix) other risks and uncertainties described in the Company&rsquo;s public filings with the
SEC. Actual results, performance or achievements may differ materially, and potentially adversely, from any projections and forward-looking
statements and the assumptions on which those projections and forward-looking statements are based.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Investor
Relations Contact:</B><BR>
Investor Relations<BR>
<U>ir@stryve.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stryve
Foods, Inc. Announces Closing of $2.9 Million Public Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLANO,
Texas, November 12, 2024 (GLOBE NEWSWIRE) &mdash; Stryve Foods, Inc. (&ldquo;Stryve&rdquo; or &ldquo;the Company&rdquo;) (NASDAQ: SNAX),
an emerging healthy snacking platform and leader in the air-dried meat snack industry in the United States, today announced the closing
of its previously announced public offering priced at-market according to Nasdaq rules of 3,670,886 shares of its Class A common stock
and commons stock equivalents and warrants to purchase up to an aggregate of 7,341,722 shares of its Class A common stock at a combined
public offering price of $0.79 per share (or prefunded warrant) and associated common warrants. Each share of Class A common stock (or
prefunded warrant) was sold together with two warrants each to purchase one share of Class A common stock. The common warrants have an
exercise price of $0.79 per share, are exercisable following stockholder approval and have a term of exercise equal to five years following
date of the stockholder approval. The closing of the offering occurred on November 12, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roth
Capital Partners and Northland Capital Markets acted as the co-placement agents for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received gross proceeds from the offering of $2.9 million, before deducting the placement agents&rsquo; fees and other offering
expenses payable by the Company. The Company intends to use the net proceeds from this offering for working capital and general corporate
purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities described above were offered pursuant to the Company&rsquo;s registration statement on Form S-1 (File No. 333-282043) originally
filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) on September 11, 2024, and which became effective on November 8,
2024. The public offering was made only by means of a prospectus, which is part of the effective registration statement. Electronic copies
of the final prospectus may be obtained for free on the SEC&rsquo;s website located at http://www.sec.gov and may also be obtained by
contacting Roth Capital Partners, LLC at 888 San Clemente Drive, Newport Beach CA 92660 by phone at (800) 678-9147 or e-mail at rothecm@roth.com,
or by contacting Northland Capital Markets at 150 South Fifth Street, Suite 3300, Minneapolis, MN, by telephone: (800) 851-2920, or by
email at fjohnson@northlandcapitalmarkets.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of that jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Stryve Foods, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stryve
is a premium air-dried meat snack company that is conquering the intersection of high protein, great taste, and health under the brands
of Braaitime&reg;, Kalahari&reg;, Stryve&reg;, and Vacadillos&reg;. Stryve sells highly differentiated healthy snacking and food products
in order to disrupt traditional snacking and CPG categories. Stryve&rsquo;s mission is &ldquo;to help Americans eat better and live happier,
better lives.&rdquo; Stryve offers convenient products that are lower in sugar and carbohydrates and higher in protein than other snacks
and foods. Stryve&rsquo;s current product portfolio consists primarily of air-dried meat snack products marketed under the Stryve&reg;,
Kalahari&reg;, Braaitime&reg;, and Vacadillos&reg; brand names. Unlike beef jerky, Stryve&rsquo;s all-natural air-dried meat snack products
are made of beef and spices, are never cooked, contain zero grams of sugar*, and are free of monosodium glutamate (MSG), gluten, nitrates,
nitrites, and preservatives. As a result, Stryve&rsquo;s products are Keto and Paleo diet friendly. Further, based on protein density
and sugar content, Stryve believes that its air-dried meat snack products are some of the healthiest shelf-stable snacks available today.
Stryve also markets and sells human-grade pet treats under the brands Two Tails and Primal Paws, made with simple, all-natural ingredients
and 100% real beef with no fillers, preservatives, or by-products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stryve
distributes its products in major retail channels, primarily in North America, including grocery, convenience store, mass merchants,
and other retail outlets, as well as directly to consumers through its ecommerce websites and through the Amazon and Wal*mart platforms.
For more information about Stryve, visit www.stryve.com or follow us on social media at @stryvebiltong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
All Stryve Biltong and Vacadillos products contain zero grams of added sugar, with the exception of the Chipotle Honey flavor of Vacadillos,
which contains one gram of sugar per serving.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cautionary
Note Regarding Forward-Looking Statements.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements made herein are &ldquo;forward-looking statements&rdquo; within the meaning of the &ldquo;safe harbor&rdquo; provisions of
the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as &ldquo;anticipate&rdquo;,
&ldquo;may&rdquo;, &ldquo;will&rdquo;, &ldquo;would&rdquo;, &ldquo;could&rdquo;, &ldquo;intend&rdquo;, &ldquo;aim&rdquo;, &ldquo;believe&rdquo;,
&ldquo;anticipate&rdquo;, &ldquo;continue&rdquo;, &ldquo;target&rdquo;, &ldquo;milestone&rdquo;, &ldquo;expect&rdquo;, &ldquo;estimate&rdquo;,
&ldquo;plan&rdquo;, &ldquo;outlook&rdquo;, &ldquo;objective&rdquo;, &ldquo;guidance&rdquo; and &ldquo;project&rdquo; and other similar
expressions that predict or indicate future events or trends or that are not statements of historical matters, including, but not limited
to, statements regarding Stryve&rsquo;s plans, strategies, objectives, targets and expected financial performance. These forward-looking
statements reflect Stryve&rsquo;s current views and analysis of information currently available. This information is, where applicable,
based on estimates, assumptions and analysis that Stryve believes, as of the date hereof, provide a reasonable basis for the information
and statements contained herein. These forward-looking statements involve various known and unknown risks, uncertainties and other factors,
many of which are outside the control of Stryve and its officers, employees, agents and associates. These risks, uncertainties, assumptions
and other important factors, which could cause actual results to differ materially from those described in these forward-looking statements,
include: (i) the inability to achieve profitability due to commodity prices, inflation, supply chain interruption, transportation costs
and/or labor shortages; (ii) the ability to recognize the anticipated benefits of the Business Combination or meet financial and strategic
goals, which may be affected by, among other things, competition, supply chain interruptions, the ability to pursue a growth strategy
and manage growth profitability, maintain relationships with customers, suppliers and retailers and retain its management and key employees;
(iii) the risk that retailers will choose to limit or decrease the number of retail locations in which Stryve&rsquo;s products are carried
or will choose not to carry or not to continue to carry Stryve&rsquo;s products; (iv) the possibility that Stryve may be adversely affected
by other economic, business, and/or competitive factors; (v) the effect of the COVID-19 pandemic on Stryve; (vi) the possibility that
Stryve may not achieve its financial outlook; (vii) risks around the Company&rsquo;s ability to continue as a going concern and (viii)
other risks and uncertainties described in the Company&rsquo;s public filings with the SEC. Actual results, performance or achievements
may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those
projections and forward-looking statements are based.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Investor
Relations Contact:</B><BR>
Investor Relations<BR>
<U>ir@stryve.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>snax-20241108.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWauCybP9z5Z8CekhvWB3bamaTyMiQRGK8ioGEN12kXwC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:SNAX="http://stryve.com/20241108" elementFormDefault="qualified" targetNamespace="http://stryve.com/20241108">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://stryve.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="snax-20241108_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="snax-20241108_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="snax-20241108_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="SNAX_ClassCommonStockMember" name="ClassCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNAX_WarrantsEachExercisableForClassCommonStockMember" name="WarrantsEachExercisableForClassCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>snax-20241108_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://stryve.com/role/Cover" xlink:href="snax-20241108.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://stryve.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snax-20241108.xsd#SNAX_ClassCommonStockMember" xlink:label="loc_SNAXClassCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SNAXClassCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="snax-20241108.xsd#SNAX_WarrantsEachExercisableForClassCommonStockMember" xlink:label="loc_SNAXWarrantsEachExercisableForClassCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SNAXWarrantsEachExercisableForClassCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>snax-20241108_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="snax-20241108.xsd#SNAX_ClassCommonStockMember" xlink:label="SNAX_ClassCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNAX_ClassCommonStockMember" xlink:to="SNAX_ClassCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNAX_ClassCommonStockMember_lbl" xml:lang="en-US">Class A Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="snax-20241108.xsd#SNAX_WarrantsEachExercisableForClassCommonStockMember" xlink:label="SNAX_WarrantsEachExercisableForClassCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNAX_WarrantsEachExercisableForClassCommonStockMember" xlink:to="SNAX_WarrantsEachExercisableForClassCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNAX_WarrantsEachExercisableForClassCommonStockMember_lbl" xml:lang="en-US">Warrants, each exercisable for Class A Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>snax-20241108_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://stryve.com/role/Cover" xlink:href="snax-20241108.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://stryve.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snax-20241108.xsd#SNAX_ClassCommonStockMember" xlink:label="loc_SNAXClassCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SNAXClassCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snax-20241108.xsd#SNAX_WarrantsEachExercisableForClassCommonStockMember" xlink:label="loc_SNAXWarrantsEachExercisableForClassCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SNAXWarrantsEachExercisableForClassCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ J(5L60=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " "HA6Q9$V#JO^X    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " "HA6Q9F5R<(Q &  "<)P  $P
M        @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *B%
M;%FHP_FEO 0  /,3   8              " @0T(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " "HA6Q9X/0ZB:H"   P#   #0
M        @ '_#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *B%;%F7BKL<
MP    !,"   +              "  =0/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( *B%;%FJQ"(6,P$  "("   /              "  ;T0  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " "HA6Q9)!Z;HJT   #X 0  &@
M    @ $=$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" "HA6Q999!YDAD!  #/ P  $P              @ $"$P  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  !,%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001493152-24-044809-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-044809-xbrl.zip
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M^%0FE"<<DL#_2M62SDH? >(M-!SBRL0'&OZ"$*H(;"4#\XR[@EDXVUERB=-
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MJT1/.+W'NLLW/79]=N7\@CX6:P)M?9WVU@5!T=9?NL0JI&0J(1D(H4AYE4(
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MHE!;_MJZVGI?< _269IPSVUI<HTP-!>G!>HRH-<:."AOZ(JK/XEQ:$(!J@_
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M9Y9$O8DEY*((H2HY2($;Y"N#>PP0RQ.T!;MMA$2K0V#A#"J#%+Y(Z9\K\D#
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MAB,PV=X\^P,9P8__^/#;J\?_'U!+ P04    " "GA6Q9:>HI@SZK  !&& 0
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MJ(_$EN?N]W4VV^#;KRYRH&24&,C8IT!MLP]E=56X^;F;QY>D3_=)AI-" ET
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M-(.F8N?9'\3\CN %EGG;.MJ>:/BP6M>TV;3(FXNA>=('KKXD';E&\<:.3#;
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MH$1!W:_(LRG8!:2!H=8Q!69070$Q@)QQK!13D0&H-5=LC00MYS^^/$J/CHY
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MRDG"EJ)WD@TKBB<V@N_8,:FHG]@[ZK(J0.HF5PYA8Y'A7;HZ.X]]L_W>1T3
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MAY+HP#>,IC\>@0F5MV)%D7OE=WM? I)X2ECF*_3;..ZFCDW#"WP?QZR:RNP
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M+;S:2RY91@D?VI3X:[L_7/+(!PT7%ZYF47%-D8 M1W(A</[0U=E^;\K3?&%
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M:[8T',9]G$/4D57AVY70;T+?U/ CCY$$LR"U-]8L247D\G+V3''[+B7O%8&
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M17/7%S5II7@=KB1*V1]OXA>SK5/@3DSKZ@.[9"LB%F % 7/8N=!7ERN$2&G
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M41C['E@[@+?+W,'>8_2![)/88/7$-9PA^M'K#;<*/80-]QPWW %*BJ@MUKX
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M\3AE/^&\!:<[*% ;&N8J'LJ'.N5]+'RD9$B'.3WFRL'R2M(=Z$)]4WM" JD
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M/(Y#9@""\TNB?]Y)X"9=K5[]R5/T5ROPI+W-C7<"X]'<8 ND4:N!!:Q9;D_
M1M_Z_F7/?&99*QH4-BR2M^:K_5;QOX6H6J89B' 3>2&Z]\#*A#8UY/;% K?&
M.CZE*!?@K6-@39'_@38<5EMHM@ZV:F*N@OF*]^^!3?P[MC= P!).OH.T$!H$
MI/GRCWIA;O[,)1R ;8:3_BC]X8&2S&C83T-2CB^@CG<A AK!M*?;KV+G)#HB
M#'DPMWV138R- L56:W6'%>C4UO"&C9=_2K:^ZR5FP387W1NN;<Z3D!MR("&/
MK7F# TAC$26S:?+."S8>EPEB*DPVUJT9@SYKTR$1KBZ+1%<(1!AK";%#-NRR
MG%[2/OG-O /]JQ,8+945V%$%FYT?TI6;@&&"G('6EI$$EL_K:,\KDC+(,&0/
MQ2+9D.0;Z;93B77*N%18LX21.)2C+.!DR!CX1,F[2L((0C"KF2NH%4IX S,$
M?2U'V7'.<?'8UFZ/6)NI&83=KW)(T=OH!?Z;&L*(K(H! T(0DX\R+G_P\!7H
MOX!DQB5-.YQ'M!;%IL>ODK*G<G9KQZ,;;[QF5U946V9-(+E8BYBI>QK@2-_K
M">3+#8+JONXX#87T5&4LB,870EL-M*XN@4R$9"MHU[::V::/BK<2-Y+EG"I'
MY+7SURA93<Z;Q6L1)Z=%)H+77GI:<HARXL)<\%VD]CC(ZO(<S,CODRD)-R[>
MB'A:U+Q^+5=2L'>8M*H?LE8I+P/2DY;<&%L(GY81,1<A=GM49>.<LW^RI]-F
MV[1NFQLKDK:\D_M61LW+.$/BB2P(M2)P-\C,940.!34\./-4:3/EP1*ZK;H=
M_B-_WYZ8K,[9+# &!$ #6J4<,.UXK/\,6G!L/P-="2R>*:1ZS7DFM49P?/7A
M%Q?EE5D%%?T;%FR?EV#+5(-$[S6V&KJD15,MY2; '>TMWO@F17B(FQZUEN1\
MM<+#Q(D$'S@Q1TJRG\Z-CSG%7#*A90\/]R'8@$J'!);UT^%<:7[MX>]#7NPM
M"!5\S91V _%@ GKGGPC^1+;Z:9Y-HAE.2%1J:1RJ"N6!D:P]\-N.E]>F7>WQ
M#4D<.$\8:ODH#+0;,IU/UYG.>\AT/EUG.E<FT_D0-^VJ=VIK9&Z]&QGF/ 30
MTZ?JQJ$ZIY"#.AE\@C1E<F"O ,$B(EU#V7TYB3C%,(L\YE%< ZL8I<7 )FD-
M#$#'W<QHEC82!P\KDHY**FT#B#6NJ8#/!]465463GV[N.0L"K28R^;&J0@)C
M7(T"_Q3!1B$YPAKLJQ3*N1%F';R*&"BY0JK];F'A0(<,N!3]?@"L;EJ7TBZJ
M^';9ISD7';0RZ#L0M@*P8>4:(R3JO/U<HS2H/'6X3C*=SB&G119<6*05ZAL@
M"RF3R(_M<\ F7[:8.K' "YT:,YP0) GX39"$( O9 VJJ*S']JBGGID@D&#%]
M18 W[%.U(.WZ\!D4B*%XWBBKR-N!!Y]7Y6(>5S;FKP,'0^V@N,;]+CF;ZA$G
M:0[5==)D%7J(!PYI+>R;)0$)PS-=&@.K;=^G)6'2HV!E@P]8$<(=-H19F?\T
MEYZ'!."2.+LB=543H>EC_$.NT(<7L,\]1#()'D;&JWBAUTL.G857Z7BZ3O >
M!)5\Q7N%-@YSN\K55\A<QN0C5*,8>>0_3OF]?3(JY7@8$B[M$_D8CG1=5[OD
M/ZT"=@TS&H[(5O(:XY8(BX21?.K@M-8%TDK]XL7.BWM9!Q*'MCVGL^S&HJU6
MQR-<]L'A?=L12.P 8!V.1ZT55"7@.O.R[VTY<EX$M](03[946@=:(GTA:)D9
MLU!,/1!L!Q%R[[@P[DY9O3$-+<;E%1PNW_QTG=TJ$^F7^A;+EAIP&TPO:B)0
M=YI62S]ID'W"49[>P&3?$DP";FX*A?NH?ULWMV3R9V:ULF$ZED*1$HVL. >G
MZEH:%ZK#Z*!R4?&M[@U*XM'WO4.3K@W*I41%V4$)!H2/(X;J="=OT#3YK*&!
M#XS,K3F.2;V94RTH!YRT52[N_\RC\.!G#RFVDRJFO'6I:MVN(_6"H@SXD\\Y
MQ4=%]X#^55Q@7\2HU2%6\F4G+$ YT,ZZP;N6TS:MI9;>B1-R=B5-@)<JWS9V
MD>G<F,MEL.&7V859*9F-ZHL=O[D!N*U).<T!4P5?JVK^P?D,K&,:*32R-H(Q
MW3,N24?CH/U07#EF1='<)/9(M#7+JK7&(F7N"5T WM52M)HHKW;;AO;YX.8S
MM*9L#834TZ'Y)2]V+/NBR$74>U#RKM1]&?BN!M-,89\:6\[D]9AK>;#1M(&5
M_X%JK[$SX?$Y(S<$P9^M@^#W$ 1_M@Z"KTP0_-&Q;CTEN;9=:VQ+6/%M/ETX
M-F,/3JP-<VN+A5>Z.H A_4WT)W =C_G!\D%C.CCVFGB*5W*<]JNNDA.^BJ8#
M0:1''*[@]#Q0/F!TJNZ Z+>Z@DIM<>AUE%[C1DL("13L\QR6, #,OZ^R[7<+
M#/^%ZLVAN=_1#C!PC34K/6;G+QV:\W?!FE.HBJEH1FU.&"Y^0C/TL83=G'Q4
MG$UEWN@ZF2MT,:(^^3 "=%N9S5WQK+MY9E8/Y-#7UBO,(EG&,8:--F"!;G9Z
M[J5]I^/3M4O0/EC +%>0W;_(YW;-$>[!$9FL"3E7L8=X@)&"PT!05,C%-UZ8
MC>-.+F"PA0D^L@H^]N.,;QN+HV#%E:UQ2YYFV7AAFKE]BZWFMY53*KJ>P^H?
MDQ"ZQ7GIUV"Z1H'H*&K#1!I]JY;F*'@18 71?/9ZE=?>W8S@[<;_<^__79]9
M-DH) #_B&@,SR.PIY$,VK_ZX79HC U6=(J/9:DT?\A'B!>.>S\;F1^C)^2+%
M= IK4E,XRUA2\$#W-])=,E[L_V'_>W+$1%Z.LZS>K4=_<Z-C^/6MP+YZ63@L
MI'.Y[<*PJ18A+HX(VH=1#EQ"$,M#+C*YD\CO@X@&187UHLN+[K-^?3BM0@_Q
M<"*=B$-SSVQ_F#O/,\)KJI+^D%7M4_(4",M2C-)4GGYDD$=5:8CVNQ@=@)%A
MI&$9V_4H7YK"EQ9SR4ZX)<X2-W+F*6Y+3&*V7A9;_ B@AL4/3%M4SD#"?9@M
M;C^"N%PXFNMWL_WI&.3<E@U"?2)EA8QQH:I@ZRS[:&Q-9F""7N,!JZQ7&WA'
MPZ+UUO4.7(4>X@XD6N%3Q5FWRX+D77M05HVJH/86$)*TIH2)-M?@+,NDAM@W
M* L*GY. NEEN^2>SYK>^>])9LX3X[0B% *%%X1.Q;L2%4K6B#+M2<H-1X>K@
M$Y>^RJ^59I6Y_3$_.4ZUHQ8F./=*8YJ3J\AQ8V6+4SD4J;Z3 KP4A*M'"1P)
M0D2C'(F</Z',/03^80J\ ?5KCK D@\Z7PB%&F-L9  P0B42C@J*(>+1(JVI;
M*@VOA';8DBK11W;?VC;MAVPE@K/-IZ4]U/9+J$TGHTJ:;YX]22_+RIX?\EJD
M&M3GU;@D"E<+"+Z3"4ZB\RN\=I0$B:Q>'$0UX'V_](0)-M"0LU_+4+@A7-J-
MD_3BTY;&(=H[RNLV4G5D2074AS<W[*=!?&/(3%-^H<!-O:\PCCXM"X@HJZ##
MXSO+;X@"/U]'@>\A"OQ\'05>1X$?XMF!5M(K)FGB$)_G5[^'BB0JG=?&4EY5
MV64Y(B98ICIA<("+O 4E/B4"-S"2F GFR:O]XQA?^_@&WP6QK__^9.?[U\F6
M#F..89Q<T7->]/I1S;MGP&,M=W+DAJ ,?H^=)&J)]I+BK7(>U1D[:.BLPUVV
MA1GL"5Y6;*6TGM%S7:/;&:JE7O:2989*F@4JEZ5 ;"&7O3>DONB?,=LRKXP3
MZ_EBU^Y.<AR=(37!I+2!$%]OQ"PI3H2V2N'87T4B)8# 0=88(H3A7RM$K5*^
MTH%@:H8M8D-KS4Q0.)@8_B>0[QII^AD][+[472.\"_$N3Y\?]W[:/3D[V#\<
M;&[\MO/CWHGIS*\'IW W[1X-CC^<WK^LB-SR_ES>[2'[]:FDO-PALA5U[(E+
M[2&O.%EGPU=CH?77$/C:%K.VP2<Z'0<'/*7D"&926*9CBBQQ4NC*.*)UF>&9
MPSD@]9#KU'C;.%336F%*9B$Z]L$8/4-U!\+SM;DA)RK0%5+9*',L+V:SE&FO
MS$%(9AP?^A/CX6V]_/'TP_N?FHL?OX7_]BRGTULS@!-C@I57$I]7_ PW5^5R
MQ7S!X]NH6XJ.>,FC93[[K@W20;I2^*>9:)EGT(W $J/X/!:]]>&["CV$+4QE
M1>^$ZGS 5.>>AG%:*UCN[5(4;9 O+INYEC5(">XE-.N0HG$\ZZ@//+[,!0J.
MM.I]C"TOBL;::TSK9;Y8-;0%&0<Y5@$@^USAL;;*$G/F^QXA%I,;#14'5+F3
MDX G ?J$K($P^GTG6XGD@F$(V2] :@<9H??PWS-A54.,) V&*]@R>S>&*4 (
M0Z9RC[@](0"V/4Z7E)RL:R$V1."M31D:QZN!P(RSO2*E2QZI*!UZ /=7WU!
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M"8),SA>.D%0$#!-]_FH\)%K/ 9L$5Z%"OUHE+F>CHT& B,ZV9-S-;;BAI]>
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M2-$IGD0H0-"3- L7Y"J2N:G?Z>RTA(N';YT+.(!R!Z*P9)6M=KO"1DE*'8S
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M1+:J_#PFK4W'![T)'X#2FF)8I.SK6DTT#*I'66)P"8UW1F.' 7(JHF7>_-5
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ME,%7(@OZ7,3(#O(R+TBZ8)25^ANIL8BX15M%(,0,'K<TZ5(":>S?G,84,F=
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M*0:R;/2N%H^&D,C.;F>(#M%% W6)5_[+KZ8^XX_; L4V(J&G?-&@CH=C(@U
MDC"?/,(<)2D#+;YOK=-95TW+D-">(TF.NF%A@03DM:;$UKQ6@;7EXV@96J7"
M[%4L\JE] V*-\'!13Q,UG+42VC+<M>0:)0?=Z1CI9TMV #;-/J>C64PE#A5(
M6R9Z7B\ZZT_L,K%3)_+T(0Y,IJ#CE6TK)+025@ED/\N9MG*>VK$:*M.+@ONR
MAM+7K^WE(=651B<XV@QY =+!.=5Y1@&;1H2O7L*V\Q#(<= 2H5K,R!K!G#5:
M3U</@'.J'>'TO(%4]_31:5KQO$[OTDH.I>K<,E,.F>F2?4=,L+RO')16D[ZD
M&3_L*B]&]6X5'X:1(:R\X1ON"#T]&,E5*0O&'M6V5J4B=*2AJ _'*UP1M)59
M//L+RM=>***:?@S=82C0V+_^OF+LS:=A,B^PVR8@AF>A?>[=Y'@<#VYSM8AD
MVR21S)/7U>4* OVVK5T%H],$'&)UZ MSS$\[*1NU4\#9-^IODE%I#\>]V%I%
M:M-@J(*UN?FLC.[Z:;$4Z<#44KXT!\F2@([F1M_:5M\Z9CL&E26JD)Q',:(7
M5)4E+1RD+\>_J385URQ^=B_-<U2_SYU\?*T(10Q):+K-KK][NATB'Y+^::68
MR3"TAH:\$2%6L/F\/<$B)IB_6B % B$;*%L6F70BZV;ZN'.Z PU)PDLA>1)4
M$)V*Q3L7%-[?2'A57<5Q_3KY0Y>KUFK/K-0,+J-&_!09L5T30<9ECCIH"ANO
MVW&ZM_N(M ?K@:"^A&]_.VM9M2UKV>;X_K^Y4-&37YYQXC2Q;"@W&U9 RPOH
M6:E-#IL]PC:AS%GXP]/4)]8-OA\BS!&F[< Z_DS5D>&:Y.IDV=Q,3N+1.:QZ
MQ=:B\MHCM;1:33*;S#?=*T;*J9FJ:;-T7O)EXU@&69YMDZ+CB#"KV)K_U672
MPC"CT61=<I&UWSX-/@01HZIHD\89LCS3?. .'L7G249JDAS]MF4RE%_T^6_;
MQEL26;>/N=X@JZPOQMK#(DWB@L/\6P=TIK6N)RX74J5KAS-8?C;1?W&CAY-[
M.,0>_CLN,"&?ZT*-0-3D5T(>8+C+M>#M=ER=1UU*E/Z%\"W$HFD"<XR V'E4
MNN03G..(D6R6)]39:3U;T4SM[3Z!RZ[;V5-NWP.T.AP_EE8L5=4*=_NIV?T*
MZZ2)5Y1J7>*Z+"RW5<S7ZC+3-= EYAP-CI5KX\%"![OKD?*O<ML5Q=Q])8PG
MMKEN) I%#C^K#IRG/7(M-.?&5=N&%\;N_4$^GG,Z1)T2BO6B)40:Q!3E1"R$
M^4=[>>FSI'DR$)B":N/8^#<6IHPE1D-\,RW2UH:N'>([-^>9Y2P!=2%<]%;S
ME9ETP:5N5+_$M:ZKQ]RC'+9A'(\]X\HWLFA5W529-DFC57.7$'<'G50G"*DA
MCC*CJIR$FE*5HVEJ*R1$,>O8_ZQ2N I(DZ^REB],$UG7/M$]D5 -._(Z\7GI
MV<GDRE-T;>H%JU#: [L\/[;NY>2CZZ$.E_HU5]LE[.93!0OUQ_A6%H0A$Q'R
MYO">T#QHNIVV2=Y"9M6*XRD<,X?3.,]497??W;=D4M6))"ER[0EP]/1E/>S[
MO%!M(]&8?Y, PY/!2H;&.[+RC._#$:\LYV8,LCR?@F[6;#^T1DZN\Z,X!DU/
M5E8=DS:1U"S '$%E<9^9X(WC*&_;7"QB:^>*KR2ZA\@TY*Z.8NY 4E%-$YS'
MK3)G Y>M["RR\,OJ8ER^NUT17RN:L-+5 99/7!26,2.WG/8,L8VF4L\G)#S+
M*@XURY$_ ST)\:!!JT]43 5".")'KI7\*O;#1U8.N-R??_325!#^YJ%K!P4C
MMH68O$3ML5ED(AZ;8H-8'"=2/("J&PSAWD OX<7G&^CE;4(OGV^@EQOHY4\.
MO91J%/O&,2.Y80,R",U/[>M!&S]>F3I=N# D3]]8,"[VSW8?PFY"5*2N^*B(
M8+L=BPGV&LK<)RN",!QF9R%6(C8<"W+$7M%0'/C,!.KXIBQ'U(TP]S3WXR>Y
M\-9_6).>5%95W*:L -\JJ]W]7,/='S8LJ=!F2 EQ'5V<"DO!3Q=Q%E^*->'!
M>$ >:<B.[0$BMD]E3K2)+K_8(=@NL\HJPNYZ@48+]/&3]X/BO.B!3;'B)&_"
M.FVUUU6+GLLBN%( ,@9Y<5$&9T9<D>?7P$0KPVDX#$8%EI]'+G;'JXMVI"J.
MH,-PIJE;(_?<')L;/C;)CB?[!AA-,KL-]JDE#9$9TJ./]U+&34ZTSGYH2!8G
M]S)L*3P7Z(?H:69[#_V^M[PM!+QAKE^69P5Z)AF)B1$ADZZ><3I#$4?QU/&$
M>DUQY(OP]S;P;5Y=Y 7,F 2U0EVJA(HCF#"X_T65_HZ  V'!86_9",MPC]AK
MR1J1@(AM"#2J3IZSTF+ *=3?"Z$SP3".!%M 3(6I=M/8U'.><T!K1+K$21VE
MP/[')I;&^@0J*(&5.U,H4+J/^W>R8R0%12?)4/T+%,4,OZ8O@U0-4[<4<DM:
MBW*-F*R6_O4)"@KR7EM$2C5198_0@5DOI]*6>3!LVKKN=KK,TWE6"4ESDIF_
MPF&!>904[C2!]3%3>I5(H@BC]FG9)Y,PJ:VPG])OLOD;@D0Z@ULQ=3=?4%XH
MHV)'.>R.RGI:73#Z5HNB J-@E-]K *5@/YCJ\NHJ.HG/D2>[#J .*TJ'JH+'
MC]"*@:,-KQ.:C[REFF3 BC=*!COVPV5$9(>47*$H0B9)'/6MVQ>][8AX^&)'
MXQIYB+C"C,M&9/F '6K'OB,$^Y9(ZC=("]I%:&%8S5'XS339SE/DH+)JNYIR
MNNB;_#$;LK:DQ^5U76ZD J!\C*U%TTPJ2H(:788E151B2U]RXLSY+_Q33&$A
M@7%0+URZ3.H(U>4U*.?:W"65^QET0Z\VE8W<&(T993IB7P//-TD5CRM-3JB7
M@/&-DTA3XL[BRX9J"R!=TCDOK=)F;89_$:],>8\O$&.'X2S09; K1N%9S @A
M+0X?&[BW0/Z;V*)A31$'M5>+2Y]<4SV>^N.5X>)A,%R$NJO'IUCL-8TLE1B@
M0 2?/F&\+[' !6QGN%^H;-^V@&P2JB@02M\P9*=B/1[,4P=+S0W7)(A!?(+6
M'F9Q/B\Q/Q-+[3@3W5!TQ[53@GW&/H,8I6(]\'NJ(__7[?^RBWGHH 7QY;K[
M5?0^=V(L (S@7A#'%V=C"_CB1&;<.B&>^)7I8 PY2)?S\]@8$?)FK(OGH?O(
M(@W' _8%B\:5&-/2A?5N-\9PQ^R.Y3&&W4>;(,-M!AEV'VVB#.L69;AC!WB]
MBV/8=4&>ZKH@9Y9A)A?'IB[(FCB%I2Z(6D*0>ZF ]W90:U%U),=>V56")AA[
MR^+X3<.K4BO98\1D<<C)J82K'*A/$7''JB$#)$1M<$%Z^NF=7:5!:/K-@8+F
M]>MH!])TV%0QN*5K<N^5WP-M4<F+X$_TV,31\R15-Z\0;BH:+SHM^DHU1VVL
MH?B1@N:!Z9HA$1AZ+":ZLH'E2\ZY\AT6<#K/N/SE.0_3+2MJ0(J:(J36INLF
ML1-HPJH*L>)M()Q;T3PEA,IXSA063@ZC=(GZ00HN7$Y%%C-(A3&SY1Q'DXC/
M>4;H]H6QW*KPBU6%1;L 5-J]J)#J<<$A<0:CF=$0K=-DHHT" 7()'KA)O98!
M43^5&0,F/QP2G<56J#^6:GX0T*+=+#2W,1N2ZB\E13O-*>BK6HYL^4A9#O'=
MV'\O&PP8"R:)[BV+[L4@@)@S6'']\C.Y/Q*!86JEO25M#TVP,E=CB91=7*O9
MH8,95&4:SG^:8GD-+VV43@WGC8H-6$L?K7P;1.CQ;--N=K$H4=] _5XOM],I
MMXI<,,]2="^9;V/24:E'Y>'L,MBD:=HW$.<6ELO5VM8 <,R(V7K2L_'_QM!W
MW1Y64[(/2TK>-$>73J77$O_:+Y6IQL/FG4[=2R:FSIN:!V8@-FAH5;:ZKS*L
M3$H@87=Q/PD!@(5N5*0^?O!(2=&+\)(36^SMR 'R33!U388EM0B.S H*A.3,
MWGFJTF'"WA3REU!A*4$6L^-*"U22\U+MG06B>(-4M1\TA4I,2M1WH9/#V'[G
M*:\MB=.%KK4<3B6FZ4I=?>ZM#6I[+GFOPG7"PF/%VV^IGF04G;#7MPI=ZQO1
M*1U)@8!+ZU90Q7K8@6FR6F_DDO/0_G'C<^+3Y96VNM%<=-OQQ2'JR+3'0!F\
M\&7HI4WM5%I%AQ7[+_P^@:,!*M(A77PJ,<BN(X_' &\,Y2"S-JGQ(UT7_=94
M&L:CQNK03R*VKG$J[6Z<2K?J5-K=.)76S:ETQP[P^@]+"ASXL6"E>_AW7:%B
MQ2YM!2D:')13-Q?&.215VZ.7Y%L/5! 5M-VBZ*G):&SJC"%F:[ 2)1RHF.I9
MQ^$$<:JXE-/_W?'@S8_(5K:_,'.:@[AJA+'^7LV1P'9/."*\0,RDX+K5>E*2
MPQ<DCZGXG<<);K0>R5NA/#M$5W!$4J"\?6R<P&?C:DY8'#OTHTR_G^027?]A
M1:XK$/8]%U W.'+A[<75I1VM\O9:G5T-[">.]MM /!/;(>K&,J**5S^AS8@Y
MU]9A<<&;5OS1<>D95*-"PL>HJBL?YF#,#L0Y\\/:CDY\T2MI-L*DOO+S@EV?
M"'G 7&[0P,\3E:.*YDT::TL9X3Y3*;*";&C;^62;'BBL*2>S2H*Z*LW>C3N3
MXZ1>_.UD#E_:??K4-1)0T,@K[+<RSED!5%FT*H9BV*_604@7^6W<P#TI4LF"
M__?9*%J8&':S=_?9SJ_MWMV-$%F384D.RDGLV/M.KKNYU%5&NOR:J9.UARJG
MBCKR';;G#9Z26) (L6.(.%WD KF)ZTQYZLM$#:'*$]G6KV\4UKE.F305G0%P
MY^J\9NR?8B"#TW69P)P1:I"=:.:.98)9'%::ZA/GM2X7,T84-'8&A.EEDJ<.
M$-,36O+:$H'5[8"4ZBOCV!8;*(!*6Y22>8Z8KSAJ%9.;<[D&H4L[:OM,1VW?
M)R5Z\QETM(G7KLGV#%7&DBH1"1?NJ<%Z!Q^IQHX"\;\,CK 8;%6EK.V "-D/
MRXL&EVZ4QPPR%4R8?>>+S_(R)]DER'.L9L!04:NN:Z'[%-H(=!^ [K <^#9)
MV!(K?KP5]4#9ZUN./0T'ZW8:7WFR$WRR0[R*;USA5Q%B:\:H&/Y\49P9UFY$
M9E+$275:<0$X'!6FQ^->D#O?)FBG1"J;2_;*,.DZ<7]VV9/@&AF?62XP.E:*
M[>D=D?UHPFH9S TU7-).<(@_/ 5N(\_79%@2J'F7E_ 0Z%(3T+T/T'J8CU7(
M^3V2S6EMP0;F.!Z(<0[;R"A5RH<2)S ^OR+'1+/\6/PBF*'A<AZ9RE\I]:_B
M_D5N_Z9._UQ2V<(DL01C=!@2O%D1QQAF#O>LBK>"2>1H;UOM<Q1>]Z!/J2*P
M/-,LX3*/FN%H"9M34@E%I78 J9:LWO15A,)4.H@E&%]6 G2@<PH&F-"V>* 1
M_)%$V_4$.6HB=M>?'(K]RJ1B&,O):2)U5TIZ+HD/U6<<)S'Y3/1W.7>, S0,
MG1<F0--3FI<TB>=^EQEP[G_^)Y$WUT18'F\B++<:87F\B;!L(BP_N<(@$9;3
ML)H7F#P'3R*'UH+)S!/^4UR-=;8O7=^8=H=B?S;+D?0W(L):%5RH-&R/G [Z
M8F>M?I84^N[22K>&>]%U0$FU CY,,M>]&P8VAZ;46.5D<VY(D4-3!IZBZN1&
M:J@FP1EF,,.*A@Q[OJ=+]4 3/\E5M/[#DCC%0"741J+];5@[OCXYX@<-ZLQ6
M35T#I!_44\YL3;]6QKYBW1;]J87BYR>@EMD?',L1"))+V(G 8@U9KE$"(2:5
M<P:UT'/+J->\!1K3;%O8Y/-0,0UQ/M09^G:Z'=LN$]9_WSY+!$S55,I=I77K
M9$8"B*J9J,2"*05F5V#!MYSP;]"SXES0>PQZB^:<CHE-:5Q=C-Q_F*6^RJ =
MU&C[H!U;E%:R(BL%RY9)@JNFPU4TGZ62\*9'0C"L*I<U^=05R$XHFTJ3#BKW
MCP[/V5YV N-;#O4TO&+W_?E<63P6*X,=D\M=]O;W8?$Y%ONZI12B]#!%#WS4
M8J5S.12*QOLX7 =*R*-<>65TH$4!)6SJW011TPZ#K<8W?\UWN'[(0N&<&Q>I
M#:B,P$#,33"GNL]IP^A_4,!-W.T+5=X"HS$9\D"4I2;DI>H%S"U*&^T+"BFP
M5C,.+_$Q*(,Q,=C7$"-NI2TE#&(5H,%J[974+<DDU<%]Q8U]CS5M"8C'>(H9
MSY( ;($IJ85;*U[^H^3_O;S4AN27=O*8) \=9,U52$50.+5<S@<BE.S :!.J
ME[3AA:5@6^6+6HJ'POGBG P4]9XK!]YUJQ56%T4^/[\0Z>46'74(5X10I85<
MP*$MX5.!!SQ,I>BC Y@PU$"&]T2S4U_F2<3>N/@S277Z <&!1WC#JVK'H!H0
M%L*B)I9#B?03I7\U]KL=)*3FJ"^+SXK6%T[H>0XZQB2DN&U9@O UOKVB(%0Y
MSK&PSC ^@IJPTGTL4T@]HRKO-MQ6G$9D"@:*GE$)B8(5GU!T*UY,Q!6KY\A4
M@#S2(/D*0DO4PQ[XV?,XBXLP-40+5/TE/L]I+U7^/8Q1"/%@XATL+LRP<&OT
M^4QBHUQ*C4I%,I7L14(2I7X]G@X[M;4PI&Z<\^NX;55P6Q0%QRQL4@Z\V2:*
MBD@5F'*R[O!5N59H>=/XG'/F:$LOO5]6TXF\ZY!+:2,+#]$J%&,IT&TI/?$$
MEYUT4:XZ8PU9+L-0.%HX7*_!0RQH2D6FO5 E8D1W09?V*(\6*G'G=SBB9<3H
M(W6GH4>]U$ >1]V*,[6N>MO@-N9CR6JFQ4_=H/G=,_%_+^^T/?)W@L[)\LWR
M\["VR16"I;(L;LW,)B54&-FVQ(O5JL9J.IENQZ5";+HOEQ\1@VFAOZE-[IP6
MR?WH-TH2/$J<(MQREA /F$=XT2TY53_%UK\FYO%D$_.XU9C'DTW,8]UB'G?J
M^*Z_YU2@J/]I"6!#AP['H>1+ .L&QT6FE&1RGFF,@&(F ]T*H==2X(P5?SBH
M,[@IFA$,)IW1HL-KR)BLXZ$W .BU'M9$ :#]Y D#>(9-\#G+K](X0F>3-D)\
M2VHL"*YK+0D"?J"E9L"[?4Z4M?D&%,"/2U R%,W!L@DF6JJV6HD( @FB# 4P
M,G/A"6!H,;G58JR+E_HT,)L]NR;#.E>@THS<5 SS&7Z9Q: 2R^X]PMSV><&;
M+XK#5&#L3/^8AJ3Y6FR1>J^:T*_AX)']3.AVX^0@D=GM('>%<'.&@?1'88GX
M0PIN>L5UR>+?YQ'EG5W42BPJEF0JK52RWQX]#7'9@@S5E)LZ[[Z.3&L6T+I
MN>U#88<!SB8>>&@$J[;"))6:*V!ALJ+J///&=\56$MM9["2GE!ZFI@RB<!J>
MQZ67NM=@'2$ACTODRT82N6K(5:7O+9?)!\,/!1L^6(N3?5^Q[!#;(XE.-I0R
M-*M2[,N.X AI0BE+!**#RFGHBNRP)A(SF\T(4T;7HP3L^4E$R=7J)U*F6:H*
M%I.=*H.*YE9BO] <L4EI-A%?[GH3,(=T^^8Q6WDCXM9D6!=VI0]5%D<SP_8I
M<A>71K; ?<DUT0Q!$3N=I\@\HHAHN<Y,7ECLV;5B#[532$RFYH46I="FK-WH
MAO=C6(F MG6T!M?T7>*0[AWEUD6@_%/B2*-T:Q/O"$%"4S;HI0Z-NT*QG=87
M/;5J'WD8:G%M@TR$_2^!(D7L/''"$U0X_C))X_/8JW'<EWODG#)O$R:9YX*F
M,EC-\?.VA6>*2VS*2%WB[>*Z!),^TOK3*:;KS32:<&6 HA[<I9 ,_&@,1S*!
M.\JGU-^<L349UN_*_N*KNIYLBO(VDL1GDN)X[3<R85O\D0JI.*(L;UMA0=('
MHCA'O9CU,#:DF+#:YM=GTK^Q'[HTNL:U^!@J1"TF(QR(F$M&B/;'OG@%GXRP
MB#O6/T,U$]0T/L@34=DQ+T+K4C@JUM$X)0K=?G!LX*<FD:.A;+8=QY(J&JI_
M.2ON.B>6ZAG3P:./(5]\QC$]*Z) D)"F.6+ "VM?"RH'$5[):*V1;D[HF@SK
MLR"152E9-B8&Q%58UIAGVUEF&QA?K=N)2O)9 4A3GESVJNAB2286*[X[BK-X
MD@A6AW;7B&NN&"=,Z7;;:(1,ME@KMJ.Z==U[9&JJ^LMGUYRX(B;_8Q9I353=
MG\X(%OIV]4EH&@^QT4[%V4FS[JH4T(RY<EW-87, UV18J0"H$2B$]D,[P^,T
MCYBF%J^-*>\WI:B9[2F)NP)QTA:,(FF4R&K#P; UP,WN69-A345\QY<>7?@G
MW ?HK9N!<I$0(3+I$:U^+>-LTL$4B_N2J7&$OW%DEQ)!646!F6Z'%287GLM.
MJ&2RW*EF&H='+I)1(NH=U^/"KP?-'V>R:?U9(S23S'31Q?\I]Z5J2;!WT@Z%
MEQ223WX6:M 6EVJ)+">H?3$4UC.$^6N_-38';$V&E?$!>QL3;MRR8"[D)X@7
MJ]4P(J5 :0%4N2Y+E+.@B)&MB?Z2B3]:HTO[VB806C?&6E.Q95#:M9-^LY5N
MB@"%,1XWV?O_U_#/NH[E^Z^$O[=NF'SG\/76*95PF".0CG C;W)D6RM[KQX>
MOKY7(U6+5QO6-6"PIQLPV*V"P9YNP&#K!@:[5X)6;O$;E38_D*QL]V8%Y^%1
MM_/I\.QH>'H:?'H[/!D>OW&#]UC3A&KU>A5-Q# RY7KL[$X&&\\S5=7'SH?5
M7BHJ3S))BK+BS WTAT64+71[-3M^P PW[W4CEVPYY,NIKQZT(Z9:Q=D#$B26
MT%J]@0;Q]D"))2/25O]>@V2\K9D'D6HZNG^,$W_TMP>/OV&6;Z_3\FW.?LL+
MN,;FLUE<(-$3-++WNJR*!9X4',8DSR-&I<!QV7MMCY.NCCNSQK(IG^&>_%'K
M_<V=7L,^/_W^G;Y+&^Z.+L^-ID8M7BSMTW)KA#_XXZ=RLVF^:[?(,KMSO=IL
MBQ_<K3,$B:S7OA";^![:!=?XJIYM?%6WZJMZMO%5K;FOZA:\/>L=GP&C\>CX
M['!_V.T<OPF&_QB>[!^>#AV#<=W<;QN/R@H=;HAG?D=7Q5E^,QK%#QM JZ/E
M!^HCZRK4OHLZM;7;8PY#0LY(&5V!6\:8F\6,B@KB_W_R3ZWB@E<MPJJ2X/$[
MQ:: O?K&%D(<NIUD8M&_2J5LX5HGW&11:G(YS4DGG]3X;TY!T&7#O2+$:6I#
M@]P2]WV!']U_'_H:#VCK<0_C\;SV4D4#&:5P#Q"'$>R'+=A;2!-J%GJ4?^F]
MN$>S<+NT12L#>FYV4/_#H^+__B^5) BOX!13TH0FBON8$>CO%//8RY=!7MRS
M6?@IEG9B)V429U]#V8Q6!JH0R70-OU._+1L3Y<$\#5T6OG(^*E5=+:SUTV]-
MN.,/*290N<>FX9=D.I^V=TXN2J\TN517]=D;.$TZ(I!12R^I(-&M<4_=QTW^
M0ZZE)W@MI4QZ2+2#)1(.UGER*4O8*C]L*UV<X$Y[G].9Z4'>[9)CA8"!.,VO
M-I?9'=_A_[?\G[5U(:QMQ]<<.47D^YXXL>BJ/"*#2:XJ Q]\&NP' ZEV>D27
MUO>5'6NSAAM)L5FLS6)M%NLG7ZP?HCT_E>36,3-YP$5VF%W&995;=<=M31DI
M03)5WS4T;R7REJKP"KIS%$^2C-V))[K\1W" EA<8A^>A4RB[V_%K<T^"W>=/
MGA"OL.32?E_WX)KOF^\4=/B?T\._'PW./IYPL.[M\;N#X<G_KNE(UWRA&"]%
MS A\B%$-'2*E"GSJ&I&\\C]K.S>O#E];B64P1W9%-/I%SK0T_MQA?M8WS-_:
M3I3>1$T3=",;:6VGAH!GMSLWZSLY!W"CO^AV;F(.[M6\? MJ[I<-5FXY5FXE
M(-<&XG:W(&YK[,WV!D2L63>,>1O^X^WAWN%9M[-W#Z%NZX$]E!]<Q;B\+X(,
M*?72!Z\'IVCEO!\>P>*\.3YY?\W@1GD:W=41W@D?QJ.=9[.;/3V'K[?.F#01
MVE4A:"[59FC_)?.70\T$62%J%[!FTX7A+4XR8E)$9\5.<)!S$8#2?LL&97'E
MVYWOR$WQ'>>TE9]BS8<&9[C;^6WP[N,P.!GN#P]_&Q[TFS<-[1",]0A-HJ%%
MK!2'9Q%K.L]2G&15?LOS=7M3LP$JK]#A6EKP+5GAWR=C\KL.ZV[GSOV X=_=
MOFXQJH8[^*%(LJKWTZ[;((K@FB^_UX'<',+-(=P<0G\N/ESDF<R$CZ?9',?U
M7=;A-$Q2[IX2L\%F8>_!PF) ('K!_?.<^?#W?N#Y]>^T'/[)E](M%,?]U-'4
M%ZM&;C8K?'>'W[3"2ARO')I;VP7^,?0<=Z*R^*\O@V,N\/XB>!>6U2;R> .1
MQSL17[MWJ4,\(-7RP[WC@W_BD7WX]NS]N]?_'U!+ P04    " "GA6Q9)MG;
M])L0  !400  "@   &5X.3DM,2YH=&WM7%MSVSBR?E>5_@,V=4XJF:(4V[GY
MMJF1+YE)K>/XV)Z9,X\0"4F(28(#@%(TO_Y\W0 I6E:\NU4SV8Q/\A";(-AH
M-+Z^H3LY_/'Z_=F;?N_PQ]/1"7X*^G-X_>[Z[/3-X;/P$V^?Q=>'1Q].?A57
MU[^>G?[]T<24?E]L;U5>7.M".7&N%N+2%+),PD BKI35DT?X$)]>_+O?'8A"
MVJDN]P5-W7KTYO#MA_/K+I7!1!8Z7^[_,SH\U^G?55@6E([>/"['KCHX?':$
M?1)=_+CX8Q@]$%Y]\@.9ZRF&K)[._($8R_1F:DU=9H/4Y,;NB\5,>_4';^KT
MTTR/M>_W]O:&VW_^WE)5>F6_U.:^U(E]V5U=>;N<JW[OK3$99KXKTZ$8E266
M34'JPNI4EU-A)N*_=H9[XKW.<VU*<5&/<YV*#Y,)*.,]S5.9&/G!>VEOE!>C
M-#4VHU?>B'/I,OF;N*QSY?Y\^7VLG=>3Y1<18(.)A[*?B[/1^8>DW[M6GR2F
MG9NY*L;*BMU$[&SMO!!/?CC[<'0JSD]_N?KEW>7I4_&XR*2;'8@ (]%%T9/'
M>?9;;0["J\>6'X2Q(H[[F1+'IJADN8POGXHGYZ.KD]'_[(NK\]'_/@4CLA2J
M4"2;J9@IF?O94K@2@J"!*I=^8FPA9)F)7,D,G.I2$&&I[2"S&I@LE/3A$[S+
M($N[;";]5$)\&7B7GH3B32:7H!7 G_&4*BA OP<-D*(*L#<-[*L >^D'18"]
MW ![2[ G#7J>O'J]E>SNOA)N)FT8T]Z)XUPZ)T8B-44!W7+>@%?:4AAP<43]
M5NNYS&$=',DE$PMIK<03K575-IU)IT1=T2/$)J=3JZ;8&2WS.GG^8CMYO;/S
M+RV-?=#(6)?8W,8]LT'8&K[>Z_<J")V)BB<XV\JJ"0"J6NZ>\DZPBDFU)&G'
MI1KFA^)4IK-( 50W<O09RMJ)L2*>G,FS?L^;J<*96;'0?B;\PJPDI&B-KIA,
MJ>Y?<RBN<?QKS()RGHN9!-()F)^43;53GQ=)(FB%.$^.<P6-RW.S8)YIE1D8
MQV195=;@;%E6@3Q, ( -FNTJ.'_,P"8F&A.62EK7(9?%DR;0=D@#*9%VW%!N
M7#3H-+,]58A2?:I42B>$)4R:UA9"(G658U/[E2G8W@FV(!&N'G_$%S2?5Y5>
MNXE,/3D(T$^A:S Z4+>X:+^7FC+3]-X-'X[-?&@^X%W)!U6J<))!F6;:M6!)
M1,=T"YD[V!O8FH <62BR7,IZJ4E%-!@'ONZQ52]W]I(7VQLM4[^WP31M5+R7
M+X9;6V)EBT WZI%564U&>NVC5IM89T5'93NPWJQ(#^>H'QIT+XV?]7O'LM(>
MAWLAK2\5K"19U7-C_2RGWYK7(5)U;*+):@&ETC&T4S- :)$B\"B!MREY7*QE
M;UG,;RCX:O<#/]?O80WX=&AL"L/D&A_5&*V)-<5M!Q@<]<H#CE7(>(J0\208
M  24R,B<,%@X/%R#R6/K.,J=*,6P0]S($4F[#"U1.KRLY)(#@O&RRUAPT@V7
M&HE@&9BO8;AH7HD@L]U4W$7'-#-,%\9R>)Q&H#,?8$]9/" ^K8RE8 %FN#)@
MY1N2O]K],)*=0BR&J E?9LJE5H\IY1@;\FX 9(B &0 <K5M7P]&N 3[BTL$;
M3N&1<?Z:?2IPP.C%PUM*I*X&V^+)6PU<GINA>/[\^6!G=V?KQ?.G ++5$(G,
M<V@/)F1-8*# ?<L@V=?33_#NY937+K1SM%*;"YX>M[D>AJ]4Y6-4N=U$E9S9
MS#3B];%*$4T(A:U!X^84M/=[ZREIT)CU)*7-# HDA?@.3$/1D J6'&!(TB%'
MREY#^F$U33II?1,9KU;=++)AO_?+3"'-FDN=DR8G0N7XPIH2C*2FTB&6(5H3
MDEMG27"U) -CQA0D092DM1-$4"03EBB)*9[80HT=8"5RDW+^A!!HYGVU_^S9
M8K$8 AS#J9F'A)#(<CC6I8U](YKST<.1AQ3K#C(19V?'1'AW=U=<(< ZSGF/
M2IQ82" AQ,)H>''$>=3Q2.SMO'JU1:2K&652^/3)[M864/+J]>Y@;_O%:TH<
M%+)BG=-+2U8P+;ZGGT,$= F]OLW8/?[9B^V76^(*6<A,O-43_'WE(2P/O:E)
M,L^?;VTEXKU&R"HKDVN7]'OOSQ,VK3@39G$_,"AV7VX/=O9VMAH.5,/BY*.9
ME<Z4WY<-(]%\ALS>$=O?+.57NY]K>$$DWD@@R,;EBM*+S(!$:3S!#)SXVG/:
MSD:"HWN%9#Z&=0ZX27'<3?+:G3>NEV)EA(.%0JZ CS]#'/B[30^YA81-14)$
M;OTC*+E,A_0*8\'^N!I_A<_%QJ\7ILXS4NVZS.5B4I-%T88YO&6B,$2YC9[H
ME ?Z/;HVB=M<F6K0B 8*Z.^R]-!1CAW];3" )5%YM@\;.%4'(/!;K<J4/A2#
M02Q$'9Z\^[EA(VQHX$W%FVIV.!@;[TVQ+U[1V-A8"+H=.\KITG$;(J#SS+"Q
MZ]'1V:DX/CT[NQB=G+P[_^'OC[8>\?/5Q>BX>8Y+1FJ032XK!]::WP[@>C,_
MHTUN_?>F6_WKRX;&''DX8) WP@?_MT\C5Q/^XJ3YHD-Z);_K$ZK&7=)?M /\
MA&@V2&ELE;P9A$AY'^Z41-N5W*L-DHLL/T3)=&#VC' 6H/7_MQ;Y)54?VQK1
MQ66_=[<T\>!V^A /L"E,(BZG<%T5NBXVEW72F"ZS)\-T>&18<]ODZ)1%6Z?:
M>^F9GLXH&/=($!(QM43(2^=5\.RARB16/G-L,>RX G1DI83W+-1C>-R#1/Q#
MYG(FK8Z/3:6+'XC6SS*5F<YSXWAPV)3)*/)PS @2DTQS[E;Z4!^Y4^4B0A.
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M"S8[KH;0+ ?D!]1%F5-JCL]46[AK+.N#>:X+\B%^"D'!=1/SBEJ((*N: EG
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M,'5CHIV SP%L.#.@^"8SOY)C6#-<N#CM4?1B8 9ZW*>Z,5#U)_I\<CRBG<:
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M'KG)-_1NP=,%3Q;\:Q@9J0<<WG-O1\DG\]ELLE(ID6D/<= 9C8)+XVP?GW8
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M%L)CX/Q,!9\Y%M:8_I)J&#QX+=VAI:MV'T@!3J=\;QGNQF7>#ZE6T^+&,?E
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MU/HY^OR9ST"F8R@3_+?O#+3:_P-02P,$%     @ IX5L64$%LIN[ P  MPX
M !$   !S;F%X+3(P,C0Q,3 X+GAS9+U7;7/:.!#^?C/W'U1_-\;0M,&%=GKD
M99B&M UID[DO'=D6H$&67$D&<K_^5K9% (,+]')\DG>?9U^DU6KI?E@F#,V)
M5%3PGN,WF@XB/!(QY9.>\VWD?ASU!P,'?7C_YQ\(?MU7KHNN*&%Q@"Y$Y [X
M6+Q#MS@A ;HFG$BLA7R'OF.6&8FXHHQ(U!=)RH@FH"@\!>BLT7H=(M<]P.YW
MPF,AO]T-5G:G6J<J\+S%8M'@8HX70LY4(Q+)809'&NM,K:PUE\WR=QA]2%6T
M(G?>#%/U=GE''R>$GV<7F"_4 \[Z3^&7SC]G?Y_WR6PZ?_BK'>($WS\-Z=>[
MZT_G5%Q?WOJMV>.B7[CLJFA*$HS@,+CJ.2:_,KU%NR'DQ&LUF[[W.+P9Y3BG
M  9+1OEL%]SO=#I>KK70"G(92F9-MSVC#K$B*\N@I35XRI7&/-K QWI%6 >?
M>85R TIW0M\44&JA,=G"*1(U)F+N@0+PK=<6F"EW@G&Z H^Q"G.CI6(#K*2N
M D&X#7+U4TK43FBAVB#$6FX1-G8-U)Y1&T[+;;;=MF^9H]N/CRN2TO)I3DPM
MY]9]OWD.-Y*1A'!])61R0<8X8Y# SPPS.J8D=I#&<D*T*4Z5XHC4VK+UC3D7
M< W@+I82(TM3"G6^$H#(U$4@!2/W$#LR"[B'NQP8E=<7T$D<1..>4RS73%EC
M,1E33G/'Y:WSD6ON6&92A&7.['K;X*JE3)'X,W^?KU-)%-#SA&Y 4/)+2#TW
MPBS*V$G4Y_CJF*7<;F-E?^WENR-CE%_:P%1*SU'4M$VGE$TE&8.,XZ5K3_,'
MI-V (K(0XZ'FTN9GM+U3I6-K LNH8J725,"(2(G4%.[ 6N<H0J?:T+^LN4'&
MCW*0]Q]FSG!X;.9 (>P%4[XQ]E\B5ZBR8W/=+,P72OABY:2:==?;[";PO=UQ
MNI"XD!KQ2N.J>V^*E_)&1+FI&HKY<BW/-2+7;T';;2Q5_!SI,4$\;\-Q05C>
M"4'L>?5V^5?[X&:1%].A3O>\GK5.=W(\PK2RDI-#6']K?R.&W,Q10?SZ =\7
MSJ^8^;<ZJ0@BD7%X=H\IA'6*_3CM-)ZGI,,.PN*+0S"#TZEN3ZB"JO.])5 .
M6/GD8L:Q'WV&E8*_+8G@(RVBV9 DH1EM3) PW.S34@:/C&F-6F:F6YHI.H N
M2D5\GS?[.)-YS#"T%=]V:@QBD6#*!YHD!@DY9J&"/IL9]+44&0RWA3D*D+K0
M'["4F&MUB:/IY9+(B"H3$PR/]4F=P/M_T^UZQ;G#\E]02P,$%     @ IX5L
M64P&3&8H"@  PW4  !4   !S;F%X+3(P,C0Q,3 X7V1E9BYX;6S575U3XS@6
M?=^J^0_9[',(@>[=::;9J1!@*C70,(3IGMT72K&51(LBI209DG^_DC]";.O:
M#DF$S0,$Y^KJW'/D:UW;LK_^NIS3U@L6DG!VWNX=';=;F'G<)VQZWOYSU.F/
M!L-ANR458CZBG.'S-N/M7__]T]]:^N?KWSN=UC7!U#]K77*O,V03_DOK&YKC
ML]9OF&&!%!>_M+XC&I@M_)I0+%H#/E]0K+#^(NKXK/7YZ.33N-7I5/#['3.?
MBS\?AFN_,Z46\JS;?7U]/6+\!;UR\2R//#ZOYG"DD KDVMOQ\CC^B9I_I80]
MGYE?8R1Q2_/%Y-E2DO.VZ3?N]O7TB(MI]^3XN-?]Z_9FY,WP''4(,[QYN)VT
M,EYL[7I?OGSIAM\FICG+Y5C0I(_3;@)G[5E_ZZMU@TWCS]WHRTU34N!Z [0D
M9S*,Y(9[2(4CI!11"[0P_W42LX[9U.F==$Y[1TOIMQ.=0K(%I_@!3UKFKQ9Z
MW:M48O6"C;)=\U5WP/7(U3C#1C.!)^=MR=!2^S[YU.L=_VP\_R-EI%8+/8(E
M,0.PW>I6ZC6,0F+O:,I?NMCSH[[O7Q:71'J4RT#@'T3-^KY/#$>(WF)D-LHT
MLF24YMP9M.9#"#N$O(7OO0;TB,;&R_M1IQSL%5K?_U\@U1PS)1^Y22"8R7!(
M[@*WU.G^0M#,!!2)&R*5O%A=+;$7*/*"!TCA*1>K=T=1T>]! MEYG!?XVNO@
MV<<.>5" 6=T(EG>,OG]4E+L\U,ZY*VS U?[@#IE/7H@?(+H;5L#/7H#V7Y'P
M'[6GG1!:O>PQ$0AD9HE](1";XMW%3_D[X "XUA,2/8]]P)Z9&) =L@+H:7]@
M[P(53KTU,7L 7.AM?Z##@2<'>OJ"'_DM6Q SF=EM&$/>]ID7)/&QL(SJBY7>
MUW?($W:_4J7\[B^02SQ! 57O'R59!T70D/ 2=#;C+ )+79"4)Z8@^!SV/],N
MA!>,<<<GAJAP/A9WE O?>"%,=;5I-[;I6AT<'O>ZLX[/YXAL"3K?V@'BL*?.
M',_'ID3:"FZZZ>&Q(DJW0Q@V.#PNQE5_6VA)&Z=C,MJKWSTHD^9IS'HS86%I
M>J/_3>'&2X69C]<9SCBL5LDKHHQI?!:FU^J84S:!R<7Z8V09@TA@4.ZE^J;F
M? 47!2EP@N0X##F0G2E"BS@/ZK27;'E+B/&&)W.B*#PDZ%CQ4']<ITB*QIB&
MW3[%QC;;[L>B3A7G!8ACNRS:-ZG[(L$=CY.*.V,T.,\\SI0>'%<T[$T/<!Q.
M]Q)D$\'GI53&M/'""#:YU4#:+2[TD?B\W3M^PV*F%?YY6XG $K)C@08427DW
M&2GN/?>7I,KHRC?9JVS6(VF93&GV 8F@6"UJ?90NFQ OXV,R)(C-=J]*Y*<'
M93* #/-2Y) 4)\?-U.*I9P&^+SF2 ^.NV>W=>H7109*=OE>R_(GTT;?^7Y$0
M SZ?<Q9"N(TG@#DQC+7=^ !JI">C -,%(YU7P@QFJ/>F*(#C'\A4B4I>(6]V
MM=0)F$B34J^YV(K];=T\V7;OVNCRKFC 1+:7@TI21ON81#E,?WA+7?J?IV3>
M:L["6532)IL63Y\^1H#R"98-*,3M7HX1Y=3V-1C? +JF:&KG-F52:W+S2 \Z
M&]J"W4LL/4$6FQ?% )(W+)O!=18PF"S<YHH'/"6Z/ ZO0ZX#*DX>UB:U%J$<
M.3BA<:M&G[$ T0>\X*)$A$W+1G"? PQ1_LDMY7\$2"@LZ*H*ZQGC1A!OPPQQ
M_]GQ1$7/L61(517RL]:-8-\*&J+_GV[I'\TPI>9&%,0JC?Z\?2,D &!#(OSK
MXT2X>C$3!1U:=1W631HG11HYI,;/;M6XQX)P7\<D*NB0,6Z$ C;,$/=?/H+[
M*^9793XV;1#OFXB+KA>XI/V:2 _1"-^UWF:[$+ 12,Z\$?3;4>_]%-M.$OP'
M(U%9@+5Q@^A/8P;)=U0!#P(A4M *,P]D76OZ"T&#_#NJ>:^8(FIEUFA\"X#S
MRMHL:U5KOJU@09X=%;H1J.34!U-F&4H1UVG+!O!M 0QR[JC C8 --'R!Z)#Y
M>/D[7A61GC%M .LVQ"#MC@K;"-F](',D5B/BE2>6K&T#B+="!IEW5,U&T![1
M<NCK(,B$1"NXR@4 FC1 AR+DH!R.RMD(X9!Y7"SXQOGN 0_T7KL:<+_P$%#8
ML '2E.,'!7)4\T8X^[XOL)3Q'Q-7KT@6BWD#Q(!0@Q? '-6_$+J3[20X::0$
M)\42.*I_(72GVTEPVD@)3HLE<%0%I] -],<[\<A?@:OO@'%SZ,]@!LEW6@+'
MV,)H[L2]X"\D6A!?ID"F17-DL $'M7!:)B?C))HN5-D+(LOF<+\)&.3<:9D<
M [OG4B'Z7[(HFYW:[)O#?QXVJ(*CJCD>$>8T"G3;5<JDUESGD8+T.BJ-S3&G
M+S""A_6F1;W)S0(%N754Y]YP<U5GQEGA.>2L5:TYMH(%>795KIK5=1),#^NO
M:\UL&B5$Z;N7,&Q)Z0]!E,9C[B0/6'P&";CR9S6M-=4P8I!V1R7GB%/B:8;8
M]%;'(0BB=L[S=K4F'( +LNVHNKP7V(P!K"?YX<UP9HFNN)M,H$P-V]>:_1+8
MH J.RLP,O*&4 1;;:I%KU21%[.!!71R5G"/L!3I1KGHGXT>S"!W(1!FK6O-N
M!0OR[*C,_,;CYZ&,5O,QI_ 2'HMAK=F&\(*$.ZHH4ZCL5*=,:DUR'BE(KZ.*
M,MG)KI;>S#S?![ZCPV99:[)!P"#GCBK-M\0VK92KITW*U=,*N=I1I9F BF[4
MU_O=W9B2:>HQF7;*+0T:P3Z$&Q+"%M,AA(C6:YDG%XMYB.I:?[!+8#6M-?DP
M8I!V5TMA Y\H[$< KPE#S-/%W#HHX Q!6:MZBU$%/*B+T^ND/S"EOS/^RD88
M2<ZP'Q4615<K@":U5J0<.2B'TRNGWSD-F$(BO.56 /N&U;0!]-L0@[0[O4@:
MWU:^/G)%C[0O8M_>H@$B%  'M7!Z\73(%!;(,X]>OD0*Q7B+M+"W:( 6!<!!
M+9S>>!SNJ-EGH4/+&=:&#6 ^CQ<DW.G]QJ,YHO0BD#H 69A_4H8-(#R/%R3<
MZ1W%5W,LICH-_B;XJYK%"WF+B+<V:(  ,&Y0"*=W#E\MWQXL$*UJ+%0A9]T$
M">R@(?X_.UXVV_<\<ZM)-"=@/A*  K!]K34H@0VJX*A,OE,S+#9G92$T$TS1
MC2!EK6JM2"7PH"Y.R^3-QSP4'I8W[&K-/0 79-MI%7P?C"GQKBE'A?/^#;,&
M<)U%"U+MM/*]0.Q9! OEK>X%]S V%X;D>I^L4'Q5<M  >:K' 0KG=BGNVP,[
M1S,DL-QX.4GAB8N"=@V0J10^J([C1U')MR5[V+]8/> )%N;FC4>\5!>ZH^?B
MR55I\UIKM5T4H&0;I??7;B9 W?US\IWEJY33PE<II'2M]%*Q[F'[S;W"ZY#]
MY5[#=:#.,B_3.F1(X(NU3*?Q.#*_S&LT]9;_ U!+ P04    " "GA6Q9%?XM
M ](+  #+CP  %0   '-N87@M,C R-#$Q,#A?;&%B+GAM;,V=76_;.!:&[Q?8
M_\#QWNP"<1P[LXMIIIU!FB:#8-(D6Z?M[!:+@I9H1XA,!I2<./]^^2')$L4C
M*9F69"]:5WH/]5)\3%*R>/3ZU^TZ10^$9PFC;T;3_8,1(C1B<4)7;T8?Y^/C
M^<GY^0AE.:8Q3ADE;T:4C7[]Y:]_0>+/ZQ_&8W26D#0^0N]8-#ZG2_8SNL1K
M<H1^(Y1PG#/^,_J$TXW<PLZ2E'!TPM;W*<F)V*$/?(3^N3_[<8'&XP'E?B(T
M9OSCA_.JW-L\O\^.)I/'Q\=]RA[P(^-WV7[$UL,*G.<XWV15:0?;@^*/#G^=
M)O3N2/ZUP!E!XGS1[&B;)6]&\KC%81\/]QE?368'!]/)'^\OYM$M6>-Q0N5Y
MB\BHC)*EV.*FKUZ]FJB]I;2EW"YX6A[C<%+:J4H6>Y,.?<U)EAQERMX%BW"N
MFKWW, A4R/^-2]E8;AI/9^/#Z?XVBT?ER5=GD+.4?"!+I*IYE#_="Y2R1)(P
M*K;=<K*TFTDYG\CX"24KG)-8'NB5/-#T7_) ?RLV7^ %24=(*@4?8+U>-<HJ
M@B:NS5X3GK#XE+[,M1GMR;[X[O#\3U2@'N^\"C<LQ^F+S-<CG=N^)"\[X[LX
M]V=:]//D96>Z%OE=;.=MR\\^O?;SFLJ-%^)3PR+9YF( (W%I4A;1T0.K(ZB!
MH2B[*IU%C7)3V9LSWJZ['!E5F4N<+53!FVR\POA>'&#VXX2D>59N&<LMZB04
M&[[*L9&L"<U/4IQE5\MYSJ*[XVV2E<=1E7PS&J"?F!60D<>\K 7F4<^I*!23
MB(F![#X?I_JDZ_ E9^M!-HISQ@:(OZ:+JGQ]DH4%H"(-&2<9V_"(/*N-Z[49
M>E8+A^M41,@)&Z'CC_/1+TJ&V!(I(?HBI?][/=D5_1*6,HJW"I#I]. G!<G\
M\OB/K^I88D:W9E0=[3U9+P@W*M*I= '& *L2B0Z9=QCZO=DQ.$9:KV'X3A1\
MQIQCFF>G.+H]W1(>)1E>I.2,\>%\/+\,9^2\M'H54\\M( S:7NC:Y+ L9@\1
M41 BNY+0DHG+P>^ Z;<;^&ZDS[Y^N1!Y&>(:!JWCFE)X)ZK3EHE,)4)?E.Q/
MCU[?#@@QHR/GXF/O%*@F] )&RZ@5CDH5'B"FM0Y(I!0I[;<E)2/1_HH]3&*2
M:$C$AQT;XC]?W[%HHV@6)1H5:N]VP0%D2K:^N<][FP.&S)8N)4AJ'#?PL3AP
M+ ]^EN*5Q;ZQWU436VV5;=S8&40CVQR9K5QID!3Y:N9W)(MX<B_OC';5HR%S
MWN@6DZVVKVG"0J!M#":AIO74L7\@JR3+N;I57HTX'=T8H'?=]7?:-L<"JS@(
M:(8X!$>+>A"JHCQQ=$SI!J<?R#WC7?@T9:ZIL9DT8:EK@F+$8@Q$0VN1%GLB
MXM\;S'/"TZ=>*%I*UUP 5DTT#%E0=-B]@8!4<K^,W'!,LT1V8+V0M*7.+S<
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M,2TQ+FAT;5!+ 0(4 Q0    ( *>%;%EIZBF#/JL  $88!  *
M  "  9M*  !E>#$P+3$N:'1M4$L! A0#%     @ IX5L6=CE#V ]1P  :,\!
M  D              ( ! ?8  &5X-"TT+FAT;5!+ 0(4 Q0    ( *>%;%DF
MV=OTFQ   %1!   *              "  64] 0!E>#DY+3$N:'1M4$L! A0#
M%     @ IX5L64CW.9CJ#P  X3T   H              ( !*$X! &5X.3DM
M,BYH=&U02P$"% ,4    " "GA6Q9(2@C4H <  !+YP  "P
M@ $Z7@$ 9F]R;3@M:RYH=&U02P$"% ,4    " "GA6Q9006RF[L#  "W#@
M$0              @ 'C>@$ <VYA>"TR,#(T,3$P."YX<V102P$"% ,4
M" "GA6Q93 9,9B@*  ##=0  %0              @ '-?@$ <VYA>"TR,#(T
M,3$P.%]D968N>&UL4$L! A0#%     @ IX5L617^+0/2"P  RX\  !4
M         ( !*(D! '-N87@M,C R-#$Q,#A?;&%B+GAM;%!+ 0(4 Q0    (
M *>%;%GZH=.)P0@  !1J   5              "  2V5 0!S;F%X+3(P,C0Q
A,3 X7W!R92YX;6Q02P4&      H "@!7 @  (9X!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:SNAX="http://stryve.com/20241108"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="snax-20241108.xsd" xlink:type="simple"/>
    <context id="AsOf2024-11-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001691936</identifier>
        </entity>
        <period>
            <startDate>2024-11-08</startDate>
            <endDate>2024-11-08</endDate>
        </period>
    </context>
    <context id="From2024-11-082024-11-08_custom_ClassCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001691936</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SNAX:ClassCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-08</startDate>
            <endDate>2024-11-08</endDate>
        </period>
    </context>
    <context id="From2024-11-082024-11-08_custom_WarrantsEachExercisableForClassCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001691936</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SNAX:WarrantsEachExercisableForClassCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-08</startDate>
            <endDate>2024-11-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-11-08" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-11-08" id="Fact000004">0001691936</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-11-08" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-11-08" id="Fact000010">2024-11-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-11-08" id="Fact000011">STRYVE FOODS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-11-08" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-11-08" id="Fact000013">001-38785</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-11-08" id="Fact000014">87-1760117</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-11-08" id="Fact000015">Post                                             Office Box 864</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-11-08" id="Fact000016">Frisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-11-08" id="Fact000017">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-11-08" id="Fact000018">75034</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-11-08" id="Fact000019">(972)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-11-08" id="Fact000020">987-5130</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-11-08" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-11-08" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-11-08" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-11-08" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2024-11-082024-11-08_custom_ClassCommonStockMember"
      id="Fact000025">Class     A Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-11-082024-11-08_custom_ClassCommonStockMember"
      id="Fact000026">SNAX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-11-082024-11-08_custom_ClassCommonStockMember"
      id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-11-082024-11-08_custom_WarrantsEachExercisableForClassCommonStockMember"
      id="Fact000028">Warrants,     each exercisable for Class A Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-11-082024-11-08_custom_WarrantsEachExercisableForClassCommonStockMember"
      id="Fact000029">SNAXW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-11-082024-11-08_custom_WarrantsEachExercisableForClassCommonStockMember"
      id="Fact000030">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-11-08" id="Fact000031">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2024-11-08" id="Fact000032">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm44829709837504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  08,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">STRYVE
FOODS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001691936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-1760117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Post
                                            Office Box 864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Frisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(972)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">987-5130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=SNAX_ClassCommonStockMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class
    A Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SNAX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=SNAX_WarrantsEachExercisableForClassCommonStockMember', window );">Warrants, each exercisable for Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants,
    each exercisable for Class A Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SNAXW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=SNAX_ClassCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=SNAX_ClassCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=SNAX_WarrantsEachExercisableForClassCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=SNAX_WarrantsEachExercisableForClassCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://stryve.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>snax-20241108.xsd</File>
    <File>snax-20241108_def.xml</File>
    <File>snax-20241108_lab.xml</File>
    <File>snax-20241108_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>27
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "SNAX",
   "nsuri": "http://stryve.com/20241108",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "snax-20241108.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "snax-20241108_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "snax-20241108_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "snax-20241108_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 26
   },
   "report": {
    "R1": {
     "role": "http://stryve.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "SNAX_ClassCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://stryve.com/20241108",
     "localname": "ClassCommonStockMember",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "SNAX_WarrantsEachExercisableForClassCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://stryve.com/20241108",
     "localname": "WarrantsEachExercisableForClassCommonStockMember",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each exercisable for Class A Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://stryve.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
